Department of Biochemistry, McGill University, Montreal, Quebec, Canada H3G 1A4
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The
Na+-K+-ATPase, or sodium pump, is the
membrane-bound enzyme that maintains the Na+ and
K+ gradients across the plasma membrane of animal cells.
Because of its importance in many basic and specialized cellular
functions, this enzyme must be able to adapt to changing cellular and
physiological stimuli. This review presents an overview of the
many mechanisms in place to regulate sodium pump activity in a
tissue-specific manner. These mechanisms include regulation by
substrates, membrane-associated components such as cytoskeletal
elements and the -subunit, and circulating endogenous inhibitors as
well as a variety of hormones, including corticosteroids, peptide
hormones, and catecholamines. In addition, the review considers the
effects of a range of specific intracellular signaling pathways
involved in the regulation of pump activity and subcellular
distribution, with particular consideration given to the effects of
protein kinases and phosphatases.
-subunit; dopamine; norepinephrine; aldosterone; protein kinase
A; protein kinase C
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
IN 1997, the Nobel Prize in Chemistry was shared by Danish researcher Jens C. Skou for his discovery of the Na+-K+-ATPase. Although the existence of an active "sodium pump" had been previously hypothesized, Skou was the first to suggest, in 1957, a link between transport of Na+ and K+ across the plasma membrane and a Na+- and K+-activated ATPase activity (307). The significance of this discovery is underscored by the subsequent publication, each year, of scores of reports relevant to various aspects of Na+-K+-ATPase structure and function. Although much information about the enzyme has become available in the years since its discovery, one area of pump research that is not completely understood, despite recent advances, is that of pump regulation.
The basic function of the Na+-K+-ATPase, or sodium pump, is to maintain the high Na+ and K+ gradients across the plasma membrane of animal cells. In particular, the sodium pump is the major determinant of cytoplasmic Na+. As such, it has an important role in regulating cell volume, cytoplasmic pH and Ca2+ levels through the Na+/H+ and Na+/Ca2+ exchangers, respectively, and in driving a variety of secondary transport processes such as Na+-dependent glucose and amino acid transport. The sodium pump, in turn, is the target of multiple regulatory mechanisms activated in response to changing cellular requirements. The requirement for modulators of the Na+-K+-ATPase is likely to be greatest in tissues in which perturbations of the intracellular alkali cation content underlie their specialized functions, in addition to those processes mentioned above (see below for specific references). Prime examples are the changes in sodium pump activity that occur in response to physiological stimuli such as nerve impulse propagation, exercise, and changes in diet. Expression of various isoforms of the sodium pump may fulfill some of the requirements for altered pump behavior (for recent discussion, see Ref. 42). However, direct tissue-specific modulation of the enzyme also underlies mechanisms of pump regulation.
One of the primary needs for sodium pump adaptation comes from changes in dietary Na+ and K+. The mediators of natriuresis and diuresis, namely, hormones that control the volume and ionic composition of blood and urine, often act directly on the sodium pump of the kidney and intestine. The function of the pump in absorption or reabsorption of Na+ and K+ and, secondarily, other solutes, requires tight regulation of the enzyme to maintain normal levels of Na+ and K+ during altered salt intake (for reviews, see Refs. 101, 160). In addition, because water and Na+ transport across epithelia are invariably linked, the work of the sodium pump is also critical to water absorption in the intestine and reabsorption in the kidney. Illustrating this are reports that impairment of the sodium pump in kidney and small intestine can be associated with the pathophysiology of hypertension (168) and chronic diarrhea (123), respectively.
In excitable tissues such as neurons (141), skeletal
muscle cells (82), and pacemaker fibers of the heart
(320), the sodium pump must reestablish the electrical
potential across the plasma membrane following excitation-induced
depolarization. Although part of this function is undoubtedly fulfilled
by the presence and distinct kinetics of the 3-isoform
in neurons, regulatory events are also likely to be involved as
evidenced by the multiple effects of various hormones on
Na+-K+-ATPase activity in these tissues. In
skeletal muscle, regulation of sodium pump activity has widespread
physiological implications. Continuous stimulation of muscle fibers
during exercise leads to dissipation of the cation gradient necessary
for muscle contraction. To offset excessive release of K+
from the muscle cells, rapid activation of
Na+-K+-ATPase activity under these conditions
is an essential means of delaying the onset of muscular fatigue and
reducing potentially toxic levels of plasma K+.
Na+-K+-ATPase regulation in cardiac muscle is particularly critical to the myocardium, where the enzyme acts as an indirect regulator of contraction (45). Thus the sodium pump controls the steady-state cytoplasmic Na+ concentration, which then determines Ca2+ concentration via the Na+/Ca2+ exchanger. Ca2+, in turn, is pumped into the sarcoplasmic reticulum (SR) by the sarco(endo)plasmic reticulum calcium (SERCA) pumps. Regulation of the sodium pump in these tissues is therefore paramount for determining the "set point" for cardiac muscle contraction and the steady-state contraction of vascular smooth muscle. Physiological regulators that act in a manner analogous to that ascribed to cardiac glycoside inhibitors of the Na+-K+-ATPase are likely to be critical for normal heart contraction. The aforementioned mechanism of increasing the force of contraction via increasing cell Na+ is considered to be the basis of digitalis therapy for cardiac insufficiency (329).
This monograph focuses on mechanisms of tissue-specific regulation of the sodium pump, with emphasis on two areas. One deals with mechanisms involving signaling pathways that result in modulations in pump activity, and the other deals with the regulation resulting from the interaction of the pump complex with other membrane components, which, in turn, may or may not be subject to modulation via other signaling cascades.
![]() |
SUBSTRATE CONCENTRATIONS AS DETERMINANTS OF PUMP ACTIVITY |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The simplest and most straightforward determinants of pump activity are the concentrations of substrates. The sodium pump is activated by Na+ and ATP at cytoplasmic sites and by K+ at extracellular sites. The most dramatic effects involve variations in cytoplasmic Na+ concentration. Half-maximal activation of the enzyme by intracellular Na+ occurs at concentrations of ~10-40 mM, which, depending on the tissue, are often at or above the steady-state Na+ concentration (for example, see Ref. 309). Accordingly, small changes in the cytoplasmic Na+ concentration secondary to activation of either various Na+-dependent transporters or Na+ channels can have dramatic effects on sodium pump activity. As described below, some hormones appear to alter sodium pump activity by changing its apparent affinity for Na+ (KNa'). Aside from its direct effects on the Na+-K+-ATPase, Na+ has been shown to induce other mechanisms of upregulation of the sodium pump. For example, Na+ influx is thought to be the first signal leading to an increase in surface sodium pumps in one kind of aldosterone-mediated short-term regulation (302).
Whereas the high affinity of the enzyme for K+ at activating sites generally precludes an effect of variations in extracellular K+ concentrations on sodium pump activity except, perhaps, in some neuronal tissues (318), K+ has been shown to act as a competitive inhibitor of Na+ binding at cytoplasmic sites (134). Therefore, variation in cytoplasmic K+ concentration, or, more likely, in the affinity of the enzyme for K+ as an antagonist at cytoplasmic Na+-activating binding sites, is a plausible mechanism for determining the set point for the physiological concentration at half-maximal activation (K0.5) for cytoplasmic Na+ activation (327).
Because the K0.5 of the Na+-K+-ATPase for ATP is between 300 and 800 mM (310), the ATP concentration in most cells is saturating for the enzyme. However, in some tissues and under certain conditions, ATP levels may fall to subsaturating levels. For example, cells of the kidney medulla are known to function under near anoxic conditions (56), and such conditions can lead to dramatic drops in ATP levels (310). Thus variations in ATP concentration or in the affinity of the sodium pump for ATP may be physiologically relevant mechanisms of pump regulation in this tissue.
![]() |
MEMBRANE-ASSOCIATED COMPONENTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Because the Na+-K+-ATPase is a
membrane-embedded protein, the nature of constituents comprising the
membrane components should be an important determinant of enzyme
function. Unfortunately, this is an unclear aspect of pump research due
mainly to the difficulty in separating such components from the enzyme
complex. As a first step toward gaining some insight into the question
of whether and to what extent tissue- rather than isoform-specific
differences in kinetic pump behavior reflect pump modulation by
components of the membrane, Munzer and co-workers (240,
241) examined the kinetic behavior of kidney pumps
delivered by polyethylene glycol-mediated fusion into another (red
blood cell) environment. In the case of pumps incorporated into
genetically low-K+ (LK) red blood cells, they obtained
unequivocal evidence of kinetic changes effected by the Lp
antigen of these red cells (see below; Ref. 353). Using the same
membrane fusion system, Therien and Blostein (324)
recently showed that the membrane environment has highly specific
effects on the interaction of kidney pumps with Na+ and
K+ on the cytoplasmic side; specifically, fusion of kidney
pumps into dog red blood cells abrogates, at least partly, the
relatively high susceptibility of kidney 1 pumps to
K+/Na+ antagonism at cytoplasmic cation
activation sites.
In general, there is little information on the nature and mechanistic basis of sodium pump modulation by specific membrane components. Many reports have focused on the role of membrane lipids. The main effects of lipids on the sodium pump are related to membrane fluidity and thickness. In general, lipids that promote bilayer formation of physiological thickness and increased fluidity tend to promote optimal Na+-K+-ATPase activity (172, 186, 221), as do negatively charged lipids such as phosphatidylserine and phosphatidylglycerol (187). The effects of cholesterol on enzyme activity are often also related to membrane fluidity (140), although specific effects of cholesterol on the sodium pump have been reported (356). Free fatty acids present in the membrane or as the products of phospholipase A2 (PLA2)-dependent regulatory pathway tend to inhibit the Na+-K+-ATPase (254).
The Lp Blood Group Antigen
A striking and mechanistically well-characterized tissue-specific modulator of the Na+-K+-ATPase is the Lp antigen of LK ruminant red cells, in particular those of sheep. The Lp antigen is so called because of its association with the L blood group antigens and its highly specific effects on the sodium pump (reviewed in Ref. 103). Evidence for the existence of this inhibitor was derived from studies on the effects of an antiserum specific for the Lp antigen; treatment with anti-Lp stimulates Na+-K+-ATPase of LK, but not of high-K+ (HK), erythrocytes (104). In addition, trypsinization of intact cells reverses the effects of anti-Lp (199), providing evidence that the inhibitor is a peptide distinct from the sodium pump itself and that the anti-Lp epitope is removed upon trypsin treatment. Experiments using anti-Lp and trypsin have led to a model of Lp-mediated inhibition of Na+-K+-ATPase whereby the antigen inhibits sodium pump activity in two distinct ways. One is secondary to an Lp antigen-induced increase in the susceptibility of pumps to noncompetitive inhibition by K+ (102) and the other to an increase in pump protein turnover during red cell maturation (352). In the pump/red cell fusion experiments mentioned above, it was observed that rat kidney pumps fused into LK red blood cells were stimulated by anti-Lp, providing unequivocal proof that the Lp antigen is a molecular entity distinct from the sodium pump. However, the exact molecular nature of the protein remains unknown.Components of the Cytoskeleton
Interactions of the Na+-K+-ATPase with components of the cytoskeleton of cells are well documented. Specific cytoskeletal proteins thought to interact with the sodium pump, either directly or indirectly, include spectrin (182), actin (190), adducin (330), pasin (193), and ankyrin (245). Generally, ankyrin appears to mediate associations between the sodium pump and other cytoskeletal proteins, although direct associations of the enzyme with pasin and actin have also been observed. The two specific domains of the sodium pump that interact with ankyrin have been recently identified (96, 361). Of these, residues in the first cytoplasmic domain (142-166 of the ratThe main consequence of interactions between the Na+-K+-ATPase and the cytoskeleton is believed to be the correct processing and targeting of sodium pumps to the appropriate membrane compartment. For example, disruptions in the cellular distribution of Na+-K+-ATPase, induced either by ATP depletion or hypoxia, are linked to alterations in cytoskeletal proteins (233, 262), and a spectrin-ankyrin complex is required for transport of pumps from the endoplasmic reticulum to the Golgi apparatus (97). Recently, a role for cytoskeletal proteins in regulating sodium pump activity has been suggested. For example, monomeric, but not polymerized, actin has been shown to activate the sodium pump by a mechanism mediated by cAMP-dependent protein kinase (PKA) (60, 61). In addition, mutant forms of adducin have been shown to stimulate Na+-K+-ATPase activity in transfected NRK-52E cells (330).
The identification of genetic polymorphisms in adducin in Milan
hypertensive strain rats and in humans has led Manunta et al.
(219) to suggest that adducin variants may affect kidney function by modulating the overall cation transport in renal epithelia, both by affecting assembly of the cytoskeleton and by modulating sodium
pump activity. In a recent report, they showed that both rat and human
adducins stimulate Na+-K+-ATPase activity by
increasing the apparent affinity for ATP (114). Interestingly, the mechanism appears to involve acceleration of the
rate of the conformational change E2(K) E1(Na) or E2(K).ATP
E1Na.ATP.
Stimulation is specific in that a stimulatory effect noted also with
ankyrin, which also binds Na+-K+-ATPase, is not
additive. In general, these findings suggest a specific interaction
between adducin and the Na+-K+-ATPase of the
kidney. It is intriguing that the effect is similar to that effected by
the
-subunit of the pump (see below). Whether interaction of adducin
with the pump involves the
-subunit is relevant to the modulatory
effect of adducin remains to be determined.
The -Subunit
Following the report of Forbush et al. (124), who studied
the pig enzyme, experiments using various ouabain derivatives resulted in the identification of a small sodium pump-associated proteolipid in
various tissues (151, 214, 284,
286). This peptide, initially referred to as "
component" or "
-subunit" (281), appeared to be
present in approximately equimolar amounts compared with the
- and
-subunits (85, 155). The initial molecular
cloning experiments indicated that the
-subunit consisted of 58 amino acids and had a molecular mass of ~6,500 Da
(228). Since then, cDNAs for the human
(185) and Xenopus laevis (25)
-subunits have also been cloned and sequenced. Sequence comparisons
show strong homology (75%) among different species, which is further increased to 93% when only mammalian sequences are compared.
Structural analysis has revealed that the
-subunit contains a single
transmembrane domain, with an NH2 terminus-out, COOH
terminus-in topology (25, 325). The
NH2 terminus, at least that of the rat sequence, has since
been shown to be somewhat longer and different than originally reported. (For details, see Ref. 326 and GenBank accession no. AF129400.1).
An intriguing feature of the -subunit structure is that it is
detected as two species with similar amino acid composition irrespective of the protein separation methods used (for examples, see
Refs. 85, 228, 304). Early evidence suggested that the two bands
detected on Western blots, henceforth referred to as
a
and
b, are the products of a single mRNA species
(228). Béguin and co-workers (25) later
showed that in Xenopus, the two bands of
are due to
alternate usage of two distinct start codons in the
-subunit
message; only one appears relevant in vivo in this species. However,
recent mass spectrometry analysis of the rat protein indicated that
a and
b are variants, most likely splice variants (194).
a has a mass of 7,184 Da,
whereas the faster migrating
b species has a mass of
7,354 Da and contains only a different NH2 terminus (6- replacing 7-residues). In fact, their amino acid sequences indicate
that they correspond exactly to two splice variants contained in the
expressed sequence tag database as noted by Sweadner et al.
(315). Recent expression studies show clearly that the
a and
b protein products of
transcription/translation have the same mobilities as the upper and
lower bands, respectively, of the kidney medulla (195).
Depending on the cell line used, additional bands, presumably the
products of posttranslational modification, are seen, namely,
'a with higher apparent mobility than
a in HEK and
'b with lower
mobility than
b in HeLa, whereas only
a
and
b are detected in HeLa and HEK, respectively.
The expression of -subunit mRNA has been investigated by Northern
blot analysis in the rat, human, and X. laevis, and it was
shown that the peptide is expressed in a tissue-specific manner in
these species. Thus, in humans,
-subunit mRNA was detected in
kidney, pancreas, and fetal liver (185), and in
Xenopus, it was detected mainly in kidney and stomach, with
trace amounts in heart, skin, and oocytes (25). In rats,
the situation is more complex, because two distinct mRNA species were
detected by using the rat
-subunit cDNA as a probe
(228). The larger of the two, at 1.5 kb, corresponds in
size to the Xenopus mRNA and was detected mainly in kidney
and spleen, with lower amounts in lung, heart, and brain. The smaller
transcript migrated at 0.8 kb, a size similar to that of human
-subunit message, and was detected at high levels in the kidney and
at very low levels in the spleen, lung, and heart. Also in the rat,
Therien and co-workers (325, 326) have
recently shown that at the protein level, the
-subunit is expressed
only in kidney tubules, with very low levels found in the spleen.
Most available data indicate that the -subunit is not expressed at
the plasma membrane without the Na+-K+-ATPase,
except perhaps in very early development, as described below. For
example,
-subunit is expressed at the surface of Xenopus oocytes only on coinjection of cRNA for the
- and
-subunits (25); immunocytochemical analysis has shown that the
expression patterns of
- and
-subunits are identical in renal
proximal tubules and collecting ducts (228), although
-subunit appears to be absent in other parts of the kidney
(13, 325). In addition, coimmunoprecipitation
of the
-subunit with both the
- and
-subunits has been
demonstrated (228). On the other hand, in their study on
the role of the
-subunit in mouse blastocyst development, Jones and
co-workers (173) have shown that the
-subunit is
expressed at high levels at the apical membrane, whereas the
- and
-subunits are present only at the basolateral membrane.
The first attempts at defining a functional role for the -subunit
indicated that this peptide is not essential for normal enzyme
function. For example, Hardwicke and Freytag (155) were able to show that separation of the
-peptide from the
complex by nonionic detergent solubilization of shark rectal gland and avian
salt gland membranes had no effect on
Na+-K+-ATPase activity. More recently, it has
been shown that the presence of the
-subunit is not necessary for
functional expression of the sodium pump in insect cells
(95), Xenopus oocytes (25), and
yeast (296). In the latter system, the
-subunit was
shown to have no effect on either ouabain-sensitive
Na+-K+-ATPase activity or
86Rb+ influx. The failure to detect
-subunit
mRNA (25, 185, 228) or protein
(325) in many tissues also supports the notion that the
-subunit is not an essential component of the
Na+-K+-ATPase.
Recent experiments have shown that the -subunit has a potentially
important functional role in some systems. Treatment of mouse
blastocysts with
-subunit antisense oligodeoxynucleotide reduced the
amount of expressed
-subunit and caused a reduction in
ouabain-sensitive 86Rb+ transport as well as
delayed blastocoele formation (173). In experiments on
cRNA-injected Xenopus oocytes, the
-subunit has been
shown to influence the apparent affinity of the
Na+-K+-ATPase for K+ in a complex
Na+- and voltage-dependent fashion (25),
although the interpretation of these results remains unclear. A role of
the
-subunit in interactions of the
Na+-K+-ATPase with K+ had
previously been suggested by Or et al. (259), who showed that the
-subunit is a component of the protein complex found in
so-called "19-kDa membranes." Such membranes are formed by tryptic
digestion following occlusion of K+ (or Rb+) by
the enzyme to form E2(K) (181). More recently,
Arystarkhova et al. (13) reported that the
-subunit
decreases both Na+ and K+ affinities of the
sodium pump when transfected into NRK-52E cells transfected with
a cDNA (13). However, the decrease in
Na+ affinity is difficult to reconcile with the following:
1) the increase in K'Na
(~10-fold) is much larger than that (2-fold) observed for kidney
compared with
-subunit-free tissues (324, 327) if one takes into account the level of expression,
and 2) a change in K'Na could
only be detected with cells expressing both
'a
and
a, and not
a alone, despite the
finding (195) that
'a appears to be
a cell-specific modification of
a. In another recent
report, the human
-subunit has been shown to induce ouabain-independent ion currents in injected Xenopus oocytes
and 86Rb+ and 22Na+
influx in baculovirus-infected Sf-9 cells (231). As
described below, it is unclear whether this channel-like function is
physiologically relevant, an artifact of high-level expression, or
peculiar to human
-subunit, for which the primary sequence at the
extracellular amino terminus is notably different from that for several
other species (231).
In addition to the aforementioned studies on baculovirus-infected Sf-9
cells, cRNA-injected Xenopus oocytes, and transfected NRK-52E cells, the possible functional role of the -subunit has recently been investigated in human HeLa and HEK cells. The initial approach was to test what effects, if any, an anti-
antiserum had on
the function of the sodium pump of rat kidney. A specific effect was
evidenced in the finding that anti-
inhibits
Na+-K+-ATPase turnover in kidney, but not in
tissues that do not express
-subunit (325), and that a
peptide corresponding to the epitope of the antiserum can abrogate the
effect (326). Further analysis of the functional effects
of anti-
showed that it stabilizes the E2 form(s) of the
enzyme. Thus the pH-dependence of the anti-
-mediated inhibition of
activity, together with the observation that Rb+ protects
against tryptic digestion of the
-peptide (325), are consistent with a role of anti-
in shifting the equilibrium of the
K+-deocclusion reaction [E2(K)
E1] toward E2(K). On the basis of the
well-documented effects of anti-Lp antigen on the kinetics of the LK sheep red blood cell Na+-K+-ATPase
(see above), it was hypothesized that anti-
mediates its effects by
disrupting interactions between the
Na+-K+-ATPase complex and the
-subunit such
that the role of the
-subunit is to shift the aforementioned
equilibrium toward E1. By transfecting the
-subunit into
HEK cells, it was recently shown that this is indeed the case
(326). These experiments with transfected cells showed
that the
-subunit stabilizes the E1 conformation of the
Na+-K+-ATPase by increasing the affinity of the
enzyme for ATP at its low-affinity site and that anti-
reverses this
increase in affinity in transfected cells (326). These
findings, taken together with the observation that inhibition of
Na+-K+-ATPase activity by anti-
in the renal
enzyme was increased at subsaturating concentrations of ATP, provide
strong support for the conclusion that anti-
reverses
-subunit-mediated effects. It should be noted that a
-subunit-mediated increase in the affinity of the enzyme for ATP may
lead to a secondary decrease in its apparent affinity for
K+ (328), which would agree with the results
of Arystarkhova et al. (13) regarding
-subunit-mediated
decrease in K+ affinity. However, it is likely to be the
change in ATP affinity that is physiologically important, as described below.
What is the physiological importance of a regulator of the affinity of the sodium pump for ATP? In most cells, ATP levels are sufficient to saturate the Na+-K+-ATPase, and therefore a modest shift in ATP affinity should not have dramatic effects. However, there are cases where ATP levels in intact cells are dramatically lowered, such as during anoxic shock. The relationship between anoxia, or hypoxia, and cellular ATP concentration has been studied in many tissues (15, 171, 191, 210, 230, 260, 310). As might be expected, dramatic decreases in ATP levels (30-90%) have been reported following brief periods of oxygen and/or glucose deprivation. In many cases, ATP concentration under anoxic conditions falls to a value that will affect Na+-K+-ATPase activity, assuming a K'ATP of 400-800 mM (310). For example, Koop and Cobbold (191) estimated that chemical hypoxia lowers the concentration of ATP in intact hepatocytes to 50-100 µM. In addition, Milusheva et al. (230) reported that incubation of rat striatal brain slices under glucose-free, hypoxic conditions for a relatively short period of time (30 min) can decrease cytoplasmic ATP levels to 10% of control, which, even assuming a relatively high starting concentration of 5 mM, translates to <500 µM. Finally, a direct correlation between hypoxia and sodium pump activity was provided by Aw and Jones (15), who observed a near total inhibition of sodium pump-mediated Rb+ uptake in hepatocytes under conditions where ATP levels dropped a mere 40%. It might be argued that in the aforementioned studies, anoxia was induced artificially, and that such conditions may not be relevant to situations in vivo. However, recent studies have shown that even in normal, disease-free organisms, at least one tissue, the kidney medulla, must function under near-anoxic conditions (reviewed in Refs. 56, 81). As is the case in most segments of the nephron, water and solute reabsorption and secretion in the medulla are under the control of the sodium pump. As such, continued pumping is crucial for proper kidney function. Therefore, the existence of a reversible regulator of Na+-K+-ATPase ATP affinity would allow for fine tuning of sodium pump activity under ATP-depleted conditions. This regulator should alter the affinity of the pump for the nucleotide only moderately, because an excessive increase would effect even greater decreases in ATP concentration (310), leading to compromised cell viability.
The -Subunit as a Member of a Family of Proteins
|
Functional studies on these -subunit-like proteins may yield
valuable information on the role of the
-subunit in regulating cation transport. PLM, CHIF, and Mat-8 have all been expressed in
Xenopus oocytes and, similarly to the
-subunit
(231), have been found to induce ion channel activity in
this system. Specifically, CHIF has been shown to induce K+
fluxes (14) consistent with its putative role in
K+ homeostasis (341), Mat-8 induces
Cl
conductance (238), and PLM appears to
have a broad substrate specificity as evidenced by its apparent
permissiveness for cations, anions, and zwitterions (192).
Mutational studies on PLM have shown that residues in the transmembrane
domain (236) and COOH terminus (73) are
important for the channel-forming ability of this peptide. Overall, the
available data indicate that members of the
-subunit family of
proteins can induce or form ion channels in Xenopus oocytes
and, in the case of PLM, in lipid bilayers (235). However,
two recent observations have cast doubt on the physiological relevance
of such channel-forming activity: 1) similar hyperpolarization-dependent Cl
conductances were observed
in Xenopus oocytes individually injected with the cRNA for a
variety of structurally unrelated small membrane proteins including
PLM, and 2) hyperpolarizing pulses, albeit of greater
magnitude, induced similar currents in uninjected oocytes (304). It may well be that the ion channel properties of
small transmembrane proteins are nonspecific and that
-subunit-like proteins have other roles in regulating ion transport.
![]() |
CIRCULATING ENDOGENOUS INHIBITORS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The finding that endogenous cardiac glycosides (ECG) exist in animals and, indeed, may have a physiological role, is relatively recent. To date, little is known about these substances because they seem to be present only at very low concentrations in the blood, yet there is evidence to support the notion that they function as endogenous sodium pump regulators (for more in-depth discussions, see Refs. 99, 154).
ECG have been isolated from mammalian blood (153) and urine (142) as well as from various tissues, in particular, the hypothalamus (333). They are believed to be synthesized in the adrenal gland (153, 197). Structurally, ECG are generally homologous to ouabain, consisting of a cholesterol core conjugated to either a lactone or pyrone ring and containing various combinations of hydroxyl, sulfate, or carbohydrate groups (99). Several compounds have been identified as ECG, including derivatives of bufadienolides (a cardiac glycoside synthesized by some toads; Ref. 159), stereo- or regioisomers of ouabain (362), and, more recently, ouabain itself (297).
The main physiological role of ECG appears to be in regulating blood pressure. Thus hypertension has been linked to increased levels of plasma ECG (287) and can result from long-term treatment with cardiac glycosides (357). The mechanism by which ECG mediate increased blood pressure is linked to the transmembrane equilibrium between Na+ and Ca2+ via the Na+/Ca2+ exchanger (reviewed recently in Ref. 44). Thus inhibition of the sodium pump in vascular smooth muscle cells and myocytes by ECG leads to an increase in the cytoplasmic Na+ concentration, causing Ca2+ to enter the cell and be sequestered in the SR. Increased Ca2+ in the SR results in greater and sustained contractions of the vascular and heart muscle fibers, directly increasing blood pressure. Such a mechanism is also believed to be the basis for the partial reversal of cardiac insufficiency following treatment with cardiac glycosides (329). It should be noted, however, that such a mechanism of blood pressure regulation by ECG is only a hypothesis. Many investigators hold the view that hypertension is primarily a renal problem and that it does not result from changes in peripheral tension (for recent discussions, see Refs. 152, 207). The properties of ECG must therefore be investigated further before a consensus can be reached regarding the physiological role of these molecules.
![]() |
HORMONAL REGULATION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The Na+-K+-ATPase is subjected to both short- and long-term regulation by a variety of hormones. Short-term regulation involves either 1) direct effects on the kinetic behavior of the enzyme or 2) translocation of sodium pumps between the plasma membrane and intracellular stores. On the other hand, long-term regulatory mechanisms generally affect de novo Na+-K+-ATPase synthesis or degradation. Of the various hormones that have been shown to alter sodium pump activity, the ones whose effects are best understood are catecholamines, peptide hormones, and steroid hormones. The regulatory role of many of these hormones as well as the known cellular mechanisms by which this regulation is achieved are described below. The focus is on short-term regulation, with a brief overview of the long-term regulatory effects of steroid hormones.
Corticosteroids
Steroid hormones, in particular, corticosteroids, have specific long- and short-term regulatory effects on the Na+-K+-ATPase. Long-term effects are generally mediated by changes in mRNA/protein synthesis induced by direct interactions of receptor/corticosteroid complexes with nuclear DNA. Though many types of corticosteroids have been shown to mediate regulation of the Na+-K+-ATPase (reviewed in Ref. 338), the most widely studied are the mineralocorticoid aldosterone and the glucocorticoid dexamethasone.Corticosteroids are synthesized in and released by the adrenal cortex.
Aldosterone in particular has long been known to have an important role
in Na+ and K+ transport in epithelial tissues
such as the kidney, and its physiological role is thought to be in
long-term adaptation to decreases in Na+ or increases in
K+ intake (reviewed in Refs. 49, 258). It has been shown
that the main effect of aldosterone and dexamethasone on the
Na+-K+-ATPase is to sustain a long-term
increase in expression of sodium pumps, observed directly or as an
increase in ouabain binding. This effect is widespread and has been
observed in toad bladder (137) and in many mammalian
tissues including kidney (346) and kidney-derived
cell-lines (302, 339, 347),
colon (131), skeletal muscle (100), brain
(144), heart (276), inner ear
(272), cultured liver cells (41), vascular
smooth muscle cells (252), and cultured cardiocytes
(169). Experiments have shown that both steroid hormones can increase mRNA expression of the - and
-subunit genes:
aldosterone increases sodium pump mRNA expression via mineralocorticoid
(type I) receptors in toad bladder (136), mammalian kidney
(347), and hippocampus (107), whereas
dexamethasone, presumably bound to glucocorticoid (type II) receptors,
has similar effects in colon (131, 343),
skeletal muscle (100), and cultured liver cells
(41). In addition, the glucocorticoid betamethasone was shown to have an age-dependent effect on sodium pump mRNA in rat kidney
and lung (68).
It has been shown that corticosteroid/receptor complexes mediate mRNA
synthesis by interacting with regulatory elements 5' of both the
1- (252) and
1-subunit
(92) genes. Corticosteroid-mediated increases in protein
synthesis of sodium pumps may be dependent on changes in cytoplasmic
Na+ concentrations, as illustrated by abrogation of the
effects in the presence of blockers of Na+ transport
(156, 169, 242). In addition,
corticosteroid effects may be facilitated by the thyroid hormone
triiodothyronine (T3) in mammals (349), but not in
amphibians (137). Interestingly, long-term stimulation of
the sodium pump by aldosterone is abrogated by inhibitors of the
protein phosphatase calcineurin in cultured Xenopus kidney
(A6) cells (285). In addition, there is evidence that
cAMP-inducible factors have a role in mediating aldosterone-dependent increases in both
- and
-subunit mRNA (3,
348). These findings suggest the involvement of a protein
phosphorylation cascade in long-term regulation by corticosteroids.
Recent experiments have shown that long-term upregulation of
Na+-K+-ATPase by corticosteroids can be isoform
specific. Oguchi and co-workers (252) first showed that
the 1-isoform, but not the
2- and
3-isoforms, is upregulated by aldosterone in cultured vascular smooth muscle cells (252). In contrast,
3-isoform is the main target for aldosterone-mediated
regulation in brain (107, 144), whereas
2-isoform responds to aldosterone/salt treatment in
heart (276).
Whereas the classic effects of aldosterone on the
Na+-K+-ATPase are on long-term expression of
the enzyme as described above, this mineralocorticoid has also been
shown to have specific short-term effects on
Na+-K+-ATPase activity. These short-term
effects may be mediated by specific membrane-associated receptors,
rather than the well-known nuclear mineralocorticoid receptors
(345). Specifically, two distinct types of
aldosterone-mediated short-term effects have been described. The first
type is dependent on increases in cytoplasmic Na+
concentration, because it is inhibited by amiloride (264,
269, 280, 302). The mechanism is
hypothesized to involve an increase in membrane permeability to
Na+, leading to an increase in cytoplasmic Na+
concentration, a signal for translocation of pumps to the plasma membrane (47, 302). This mode of regulation
does not involve synthesis of new protein, because it is not sensitive
to either actinomycin D or cycloheximide, inhibitors of nucleic acid
and protein synthesis, respectively (47,
302). A second type of short-term aldosterone-mediated
upregulation of Na+-K+-ATPase has been observed
in the rat cortical collecting tubule (18,
129) and A6 cells (30, 268). It
is not inhibited by amiloride, nystatin, or amphotericin B or by
incubation in the absence of extracellular Na+, and thus it
is not dependent on increases in cytoplasmic Na+
concentration. This type of modulation is sensitive to actinomycin D
and cycloheximide and is partly stimulated by the hormone T3 (18, 29, 129, 268).
The increase in activity may be secondary to changes in the number of
plasma membrane sodium pumps (268) or to an increase in
the intrinsic affinity of the enzyme for Na+
(29). Recent findings suggest that the
Na+-independent aldosterone-induced increase in
Na+-K+-ATPase activity is isoform specific
because 1 pumps, but not
2 pumps,
transfected into A6 cells were affected (270).
Catecholamines
Although many catecholamines have been shown to affect Na+-K+-ATPase activity, the two most studied catecholamine regulators are norepinephrine and dopamine. They often act antagonistically as illustrated by their distinct roles in regulating salt reabsorption in the kidney (for reviews, see Refs. 8, 226).Dopamine is a natriuretic factor synthesized in the kidney proximal tubule. It acts in both paracrine and autocrine fashion (for reviews, see Refs. 6, 168, 203). Dopamine was first shown to be an inhibitor of Na+-K+-ATPase activity in the kidney proximal convoluted tubule (PCT; Ref. 7), but similar effects have since been observed in other regions of the kidney, namely, the medullary thick ascending limb (mTAL; Ref. 9) and cortical collecting duct (CCD; Ref. 292), as well as in cultured Madin-Darby canine kidney (MDCK) cells (301), neurons (37), arteries (279), retinal cells (306), aortic smooth muscle (278), small intestine (340), and lung (19). The overall consensus is that dopamine inhibits the Na+-K+-ATPase, and in the kidney, this represents a physiologically important mechanism for regulating salt reabsorption during high salt intake (see for examples Refs. 16, 36, 248). Illustrating this point is the observation that mechanisms of dopamine-dependent sodium pump modulation are often compromised in old (179, 340) and hypertensive (71, 149, 167, 178, 248, 249) rats.
Dopamine-dependent inhibition of Na+-K+-ATPase
appears to be both age related and cell specific (127). In
the kidney, inhibition of sodium pumps in proximal segments of the
nephron (for example, the PCT) is mediated through both types of
dopamine receptors, DA1 and DA2, and involves G
protein-linked, PKC-dependent pathways (7,
32, 34, 35, 130,
177, 291), whereas in distal segments (mTAL
and CCD), mainly DA1 receptors and PKA-associated pathways
appear to be involved (9, 291,
292, 321). However, this receptor-type
assignment is probably an oversimplification, because PKA-mediated
pathways seem necessary for modulation of the enzyme in the PCT
(32) and PKC-mediated inhibition has been observed in MDCK
cells, a cell line derived from the distal part of the nephron
(300, 301). A recent study has shed some
light on this issue by showing that PKC-mediated pathways may be
involved in short-term responses to dopamine inhibition, whereas PKA
may have a role in long-term responses (271). Throughout
the nephron, PLA2-activated elements, specifically,
arachidonic acid and its metabolites, also have a role in
dopamine-mediated inhibition (167, 292,
294). The recent observation that dopamine inhibits the
ouabain-sensitive component (3-isoform), but not the
relatively ouabain-resistant component (
1-isoform), of
rat rod cells (306) has raised the further possibility
that dopamine may act in an isoform-dependent fashion in some systems.
Many of the mechanistic details of regulation of the Na+-K+-ATPase by protein kinases will be discussed below, but two aspects particular to regulation by dopamine should be mentioned at this point. First, it was recently demonstrated by Chibalin et al. (77) that dopamine-activated PKC signaling pathways result in endocytosis of pumps and that direct phosphorylation of the Na+-K+-ATPase at a specific serine residue (Ser-23 of the rat enzyme, a putative PKC phosphorylation site) is involved (78). Second, the PKA-activated pathway of dopamine inhibition seems to involve phosphorylation of both the sodium pump and the so-called dopamine and cAMP-regulated phosphoprotein (DARPP-32), the latter being an inhibitor of protein phosphatase 1 (PP1; Refs. 9, 126). In combination, the two mechanisms help to keep the enzyme in an inactive phosphorylated state.
Despite the present consensus that dopamine is a specific inhibitor of the Na+-K+-ATPase, at least when it binds to DA1 receptors, two studies have shown that DA2 agonists coupled to a pertussis toxin-sensitive G protein can stimulate Na+-K+-ATPase activity through a decrease in cellular cAMP levels (166, 354). Aizman et al. (4) have recently resolved this apparent dichotomy by showing that activation of DA1 receptors in striatal neurons results in sodium pump inhibition, whereas DA2 stimulation activates sodium channels, thereby increasing cytoplasmic Na+ and presumably activating the Na+-K+-ATPase.
Besides dopamine, other catecholamines have marked effects on Na+-K+-ATPase activity. In particular, adrenergic agents such as epinephrine and norepinephrine have been found to specifically stimulate sodium pump activity (for examples, see Refs. 1, 12, 20, 69, 94, 150, 162, 175, 314, 342). Like dopamine, their effects on activity are probably tissue specific. For example, epinephrine seems to be involved in stimulating K+ uptake by skeletal muscle after exercise-induced hyperkalemia (reviewed in Refs. 84, 208), whereas norepinephrine, acting as a dopamine antagonist, appears to have a role in Na+ reabsorption in the nephron (reviewed in Refs. 8, 226). In addition, several catecholamines, including norepinephrine, act as neurotransmitters in the central nervous system. Their likely importance as stimulators of Na+-K+-ATPase in neural tissue is to reestablish the electrochemical cation gradient across the cell membrane following transmission of electrical impulses (reviewed in Ref. 158).
In addition to these tissue-specific effects, adrenergic catecholamines may increase the susceptibility of the sodium pump to inhibition by ethanol (176, 277), although the physiological relevance of this observation remains unknown.
Adrenergic catecholamines modulate
Na+-K+-ATPase activity through two general
mechanisms. The first is nonreceptor mediated and involves direct
effects on the enzyme or chelation of inhibitory divalent metals
(86, 283, 313). The
physiological relevance of this mode of regulation is unknown, but the
effects seem to occur only at very high concentrations of catecholamine
(313). The second pathway, more likely to be
physiologically important, is more complex and involves stimulation via
-adrenergic or
-adrenergic receptors and both PKC and PKA
pathways. The role of different protein kinases in catecholamine
stimulation of Na+-K+-ATPase activity appears
to be tissue specific. Thus catecholamine-dependent increases in cAMP
levels, and, therefore, stimulation of PKA, have been shown to activate
Na+-K+-ATPase of brown adipose tissue
(162), ventricular myocytes (132), kidney
cortex (139), smooth muscle of the stomach
(234) and arteries (344), skeletal muscle
(206), and macrophages (98), whereas
PKC-mediated pathways appear to be responsible for sodium pump
stimulation in hepatocytes (217), ventricular myocytes
(342), and skeletal muscle (206). Regulation
can be mediated through
-adrenergic receptors (12,
342),
-adrenergic receptors (1, 175), or both (162, 314).
Generally,
-adrenergic stimulation is associated with activation of
PKA pathways, whereas
-adrenergic agents stimulate PKC-dependent
effects. Paradoxically, the
-adrenergic receptor agonist
isoproterenol stimulates Na+-K+-ATPase activity
in most tissues but inhibits it in kidney medulla (139),
brain (121), and COS-7 cells (75). These
contradictory results have been explained recently, at least for the
mTAL enzyme, where PKA agonists were found to stimulate the pump under
oxygenated conditions and inhibit it under nonoxygenated conditions
(188). The mechanism of catecholamine regulation of the
Na+-K+-ATPase was investigated recently by
Bertorello and co-workers (40), who showed that in lung
alveolar cells, isoproterenol increases the number of sodium pumps at
the plasma membrane through a PKA-mediated mechanism involving the
cytoskeleton but not direct phosphorylation of the pump. Isoproterenol
has, however, been shown to mediate direct phosphorylation of the
sodium pump, either at a PKA site, as observed with the rat enzyme
transfected into COS cells (75), or at a PKC site, as seen
with the brain enzyme (121). Interestingly, both effects
appear to be mediated through PKA activation. These complexities are
not surprising in view of the varied nature of protein kinase effects
as described below.
In the kidney proximal tubules, stimulation of the sodium pump by
-adrenergic agents has been shown to involve protein phosphatase 2B
(PP2B), a Ca2+- and calmodulin-dependent phosphatase also
called calcineurin. For example, an inhibitor of calcineurin, FK-506,
blocks oxymetazoline-dependent stimulation of the pump, whereas a
calcium ionophore, A-23187, mimics it (12). Because the
actions of norepinephrine in the kidney appear to counter the
inhibitory effects of dopamine, it has been suggested that the sodium
pump is regulated in this organ by the antagonizing actions of
calcineurin, which would serve to keep the pump in an active,
dephosphorylated state, and protein kinases, which would keep the
enzyme in an inactive, phosphorylated form (8,
11, 226).
Although it is clear that catecholamines have highly specific effects
on the Na+-K+-ATPase activity in most tissues
and cells, the role of specific signaling pathways in catecholamine
regulation of the sodium pump remains controversial. An example in
point is the recent report showing that both adrenergic ( and
)
as well as dopaminergic (DA1) receptors transfected into
COS-7 cells are linked to PKA-activated pathways (23). It
is unclear how receptors that activate similar signaling mechanisms can
mediate opposite effects.
Peptide Hormones
Peptide hormones comprise a major class of Na+-K+-ATPase regulators. The peptide hormone whose effects on the pump have been best characterized is insulin, a major metabolic hormone that regulates glycolytic storage and plays an important role in K+ homeostasis. In particular, increased uptake of K+ by various tissues is a well-known effect of insulin and has been ascribed mainly to stimulation of the Na+-K+-ATPase (reviewed recently in Ref. 316; see also Ref. 106). Insulin modulates cell functions by binding to the insulin receptor, which results in activation of a variety of intracellular signaling processes.There are several mechanisms of short-term effects of insulin on the
Na+-K+-ATPase. One example is the
insulin-mediated translocation of sodium pumps from intracellular
stores to the cell surface. The first evidence was obtained, and later
substantiated, in experiments with frog skeletal muscle
(145, 256). Such rapid translocation is
considered to be the main mechanism of pump stimulation in skeletal
muscle (reviewed in Refs. 106, 316). Insulin-dependent increases in
surface pump expression are independent of amiloride (83,
135) and cycloheximide (145) and are thus not
secondary to changes in cytoplasmic Na+ concentration and
protein synthesis, respectively. Experiments on rat skeletal muscle
have shown that the effect of insulin on cell-surface expression of
pumps is specific to oxidative slow-twitch muscles, rather than
glycolytic fast-twitch muscles (200), and to pumps
comprising 2
1 heterodimers, with
increases in
-1 and
2 not detected
(165, 222). Short-term insulin-mediated
sodium pump stimulation can also be secondary to an increase in the
cytoplasmic Na+ concentration. For example, increases in
cell Na+ are a consequence of insulin stimulation of the
Na+-K+-2Cl
cotransporter or
Na+ channels in adipocytes (57,
289) or of the Na+/H+ exchanger in
hepatocytes (216). Another short-term route of insulin-mediated upregulation of Na+-K+-ATPase
activity has been observed in the kidney. In studies of the
Na+-K+-ATPase of kidney cortical tubules,
insulin appeared to increase the apparent affinity of the enzyme for
Na+ (111, 113). As with
insulin-mediated increases in Na+ concentration, this can
result in stimulation of the sodium pump in normally low
Na+ cells.
In addition to the aforementioned short-term mechanisms of regulation, insulin also has long-term effects on the Na+-K+-ATPase. These effects are complex and have been evidenced in both increases and decreases in pump activity, the latter being particularly relevant to diabetes (for review, see Ref. 316).
Despite the clear evidence for short-term regulation of the
Na+-K+-ATPase following the administration of
insulin, the mechanisms remain largely unknown. It has been shown that
PKC may have a role in the insulin-mediated activation of
Na+-K+-ATPase in cultured rat skeletal muscle
cells (288). More recently, Sweeney and Klip
(316, 317) have shown that inhibition of
specific kinases, namely, 1) the phosphatidylinositol
3-kinase, 2) a specific isoform of PKC (PKC-), and
3) p38 MAP kinase, all abrogate the insulin effect on
Na+-K+-ATPase activity in 3T3-L1 fibroblasts.
In addition to their independent cellular roles, signaling cascades
effected by these kinases converge on the PLA2 pathway,
indicating that regulation of the Na+-K+-ATPase
by insulin may involve arachidonic acid and its metabolites as
described below. A role for tyrosine phosphorylation in
insulin-mediated pump regulation has also been demonstrated
(112).
As mentioned above, insulin is the most widely studied peptide hormone regulator of the sodium pump. However, many other such hormones have specific regulatory effects on the enzyme. In particular, parathyroid hormone has been shown to specifically inhibit the pump through a pathway that involves a Ca2+-independent PLA2 (93). Another peptide whose effects on the pump have been widely studied is angiotensin II, which appears to increase the affinity of the enzyme for intracellular Na+ in a PKC-dependent mechanism (59). Other peptide hormones that modulate pump activity are insulin-like growth factor I (205), epithelial growth factor (112), vasopressin (125, 350), atrial natriuretic peptide (26, 295), the cytokine interleukin-1 (358), and endothelin (359).
![]() |
SIGNALING EVENTS INVOLVED IN HORMONE ACTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Most of the hormones that regulate the
Na+-K+-ATPase do so through signaling
mechanisms that modulate the activities of a group of protein kinases,
phospholipases, and phosphatases. The interplay between the main
effectors of regulation of the sodium pump and their effects on the
Na+-K+-ATPase are shown in Fig.
2 and described below.
|
PKA
cAMP-activated protein kinase, or PKA, is activated by the intracellular accumulation of cAMP (reviewed in Ref. 22). The enzymes that regulate cAMP levels in the cell are adenylate cyclase, which synthesizes it, and cAMP phosphodiesterase, which degrades it. Therefore, signals that activate or inhibit these two enzymes affect cAMP levels and thus PKA activation. Increases in cAMP concentration can be effected by incubation with various hormones (as described in HORMONAL REGULATION), cAMP or cAMP analogs (such as bromo-cAMP or dibutyryl-cAMP), stimulators of adenylate cyclase (e.g., forskolin), or inhibitors of phosphodiesterase (e.g., IBMX). Effects of cAMP levels on Na+-K+-ATPase activity have been observed in various tissues, and the nature of the effect varies in a tissue-specific manner as shown in Table 1. The reason for this variability is unclear, although Cheng et al. (74) have recently shown that in COS cells, the concentration of Ca2+ ions is an important determinant of whether PKA inhibits or stimulates the pump. This finding is especially intriguing in light of the relationship between cytoplasmic Ca2+ and Na+ concentrations (see CIRCULATING ENDOGENOUS INHIBITORS; see also Ref. 45). In addition to tissue-specific effects, there is evidence that PKA affects the Na+-K+-ATPase in a species-dependent manner. For example, following incubation with cAMP, sodium pump activity of salivary glands is stimulated in the dog (189) but unchanged in the rat (223).
|
The mechanisms by which PKA alters
Na+-K+-ATPase activity are varied and
complex and have only recently begun to be investigated. The most
straightforward effect of PKA is through direct phosphorylation of the
sodium pump, which is suggested to be the mechanism of action of enzyme
inhibition by -adrenergic agents, such as isoproterenol (see, for
example, Ref. 75). Bertorello et al. (39) first showed
that the shark rectal gland and rat kidney enzymes are phosphorylated
by PKA in vitro, with 1 mole of phosphate incorporated per mole of
enzyme. Similar results were obtained with the enzymes of duck salt
gland, Bufo marinus, and X. laevis
(80). It was later shown that PKA phosphorylates the pump
in vivo and that the site of PKA phosphorylation is at Ser-943 (note
that the numbering of amino acids used in this monograph includes the
posttranslationally cleaved NH2-terminal 5 amino acids) in
the enzyme of rat (120) and B. marinus
(24). In the former study, Fisone and co-workers (120) also showed that phosphorylation of Ser-943 results
in inhibition of enzyme activity, an effect abrogated by mutation of
the serine residue to alanine. Similar experiments by Andersson et al.
(5) showing that PKA-induced phosphorylation and
inhibition of activity in rat
1-transfected COS-7 cells
is not associated with internalization of the pumps have led these
authors to suggest direct effects on the catalytic turnover of the
enzyme. Finally, Kiroytcheva et al. (188) recently showed
that there is a correlation between PKA-dependent phosphorylation of
the sodium pump and activation of ouabain-sensitive Rb+
uptake and Na+-K+-ATPase activity in
oxygenated, but not hypoxic, conditions. However, the role of direct
phosphorylation by PKA in regulating sodium pump activity is not
straightforward. Recent experiments have shown that phosphorylation of
Ser-943 plays a permissive role in allowing phosphorylation of the pump
by PKC at Ser-23 (76). Consistent with a dependence of
PKA-mediated phosphorylation on enzyme conformation, Feschenko and
co-workers (116, 119), using rat enzyme and
purified PKA, found that phosphorylation of Ser-943 occurs mainly in
the presence of stabilizers of the E1 enzyme conformation.
Although direct phosphorylation of the
Na+-K+-ATPase appears to correlate with the
well-documented PKA-mediated stimulation of enzyme phosphorylation and
ouabain-sensitive 86Rb+ uptake in renal
proximal tubules (63), there is evidence to support the
notion that the activation is secondary to an increase in plasma
membrane pumps (64). Perhaps related to this are the observed PKA-induced increases in plasma membrane pumps of MDCK (323) and Schwann cells (312).
Although direct phosphorylation of the Na+-K+-ATPase by PKA is an attractive simple mechanism for PKA-mediated regulation of the enzyme and appears to apply to at least some systems, other more complex mechanisms have been observed. Lingham and Sen (209) were the first to suggest that PKA required the presence of an intermediate protein to mediate its effects on the sodium pump in rat brain. More recently, Satoh et al. (293) showed that PKA inhibits Na+-K+-ATPase activity in the renal collecting duct by activating the PLA2 pathway, specifically by increasing synthesis of eicosanoids that presumably downregulate Na+-K+-ATPase activity. Activation of PLA2 is also suggested to be the mechanism of PKA-mediated pump inhibition in mTAL under nonoxygenated conditions (188). In other systems, PKA appears to activate a protein phosphatase inhibitor, which in turn alters sodium pump activity (9). In addition to the foregoing, the cytoskeletal protein actin has been postulated to have a role in mediating PKA regulation of the rat kidney sodium pump. Cantiello (61) showed that phosphorylation of monomeric actin by PKA prevented the actin-mediated stimulation of the sodium pump, whereas phosphorylation of polymeric actin promoted it. Finally, in some cases, PKA does not regulate the sodium pump directly but, rather, alters the function of other Na+ transporters, leading to changes in cytoplasmic Na+ concentration, which in turn alter Na+-K+-ATPase activity (164, 312).
In recent years, isoform-specific effects of PKA have been reported in
some systems. Whereas Nestor et al. (247) showed that the
PKA activators forskolin and IBMX effect a significant inhibition of
the rat 1-,
2-, and
3-isoforms in transfected HeLa cells, Blanco and
co-workers (43) later reported that treatment of Sf-9
cells transfected with the individual rat isoforms with dibutyryl-cAMP results in inhibition of
1- and
2-isoform
pumps, activation of
3-isoform pumps, and direct
phosphorylation of all three isoforms (43). In studies
with ventricular myocytes, Gao et al. (133) have shown
that the targets of PKA-dependent effects of
-adrenergic agents are
pumps comprising the
1- but not the
2-isoform (133).
PKC
The cascade that results in activation of PKC is usually initiated by activation of the membrane-bound phospholipase C, which cleaves phospholipids into two components: phosphatidylinositol trisphosphate, which in turn increases cytosolic Ca2+, and diacylglycerol (DAG; for a recent review, see Ref. 211). DAG allows the inactive, cytoplasmic form of PKC to bind to the membrane and increases its affinity for Ca2+ and phospholipids, its final activators. Activated PKC is a potent regulator of many enzymes, including the Na+-K+-ATPase. Experimentally, increases in PKC can be achieved in the cell by incubation in the presence of phorbol esters or DAG analogs (66). As is the case with cAMP/PKA-mediated regulation of the Na+-K+-ATPase and as shown in Table 2, the effects of PKC activation on the enzyme are varied and tissue specific. In particular, Table 2 highlights discrepancies in the effects of PKC on the Na+-K+-ATPase of renal proximal tubules (33, 38, 62, 109, 257) and OK cells (a cell line derived from proximal tubules of opossum kidney) (78, 79, 229, 267), where PKC has been shown to mediate either stimulation or inhibition of the enzyme, as discussed below.
|
The question of the mechanisms of PKC regulation of the
Na+-K+-ATPase is controversial. The
aforementioned dichotomy regarding the enzyme of proximal convoluted
tubules illustrates the many contradictions present in the literature.
Efendiev et al. (105) have recently shed some light on the
subject by showing that the nature of the effect of PKC on the sodium
pump depends on the isoform of PKC involved. In addition, and similarly
to PKA, the nature of PKC effects is dependent on the Ca2+
concentration, at least in COS cells (74).
Mechanistically, PKC-dependent activation of the
Na+-K+-ATPase in the proximal nephron appears
to be secondary to an increase in Na+ influx, possibly via
the Na+/H+ exchanger (38), and
seems to be an oxygen-dependent process (109). Inhibition
of proximal tubule enzyme by PKC, on the other hand, is mediated by one
of two mechanisms. The first involves activation of the
PLA2 pathway (257) and is discussed below. The
second involves direct phosphorylation of the sodium pump by PKC at
Ser-23 of the -subunit, leading to endocytosis of pumps as observed
by Chibalin and co-workers using
1-transfected OK cells
(78, 79). Endocytosis secondary to direct
phosphorylation of the sodium pump is also the suggested mechanism of
PKC-mediated inhibition of the Na+-K+-ATPase in
Xenopus oocytes (335, 336). As
already mentioned, phosphorylation of the rat enzyme at Ser-23 appears
to require prior phosphorylation at the PKA site, Ser-943
(76). Taken together with the fact that PKC-mediated
internalization of sodium pumps is postulated to be the mechanism for
dopamine-dependent inhibition of activity in proximal tubules
(78), this observation may explain the requirement of both
DA1-activated PKA- and DA2-activated
PKC-mediated pathways for the full dopamine effect in this tissue
(32, 37). The observation that PKA mediates
PKC phosphorylation in nerves (50) shows that this type of
mechanism may not be restricted to the kidney.
As mentioned above, direct phosphorylation of the
Na+-K+-ATPase is one of the mechanisms by which
sodium pump activity is regulated by PKC. Such phosphorylation was
first shown in vitro for the duck salt gland and dog kidney enzymes
(213) and subsequently for the enzyme of shark rectal
gland and of rat kidney (39) and B. marinus and
X. laevis kidney (80). Middleton and
co-workers (229) showed that phosphorylation of the sodium
pump by PKC can occur in vivo. Their results showed that treatment of
intact OK cells with the PKC activator phorbol dibutyrate results in
phosphorylation of a protein that comigrates on SDS-PAGE with the
-subunit of the sodium pump, as well as inhibition of
Na+-K+-ATPase activity. Similar treatment of
the enzyme of LLC-PK cells was without effect. Identification of the
PKC-phosphorylated residue has been hampered by the presence of several
putative cytoplasmic PKC phosphorylation sites on the
-subunit of
the sodium pump (see, for example, Ref. 118). Nevertheless, the general
consensus is that PKC phosphorylation occurs primarily at the
NH2 terminus of the catalytic subunit in vivo. For example,
the B. marinus enzyme is phosphorylated by PKC in intact
transfected COS-7 cells mainly at Thr-15 and Ser-16 (24),
whereas the mammalian enzyme is phosphorylated at low levels on Ser-16,
and in the rat, at higher levels on Ser-23 (118).
Feschenko et al. (119) have recently examined two
interesting aspects of phosphorylation of the
Na+-K+-ATPase by PKC. They found that in vitro
phosphorylation of the rat
1-enzyme by purified PKC is
facilitated by agents that stabilize the E2 conformation of
the enzyme and that the Na+-K+-ATPase itself
can stimulate PKC autophosphorylation. The physiological consequences
of these observations have yet to be determined. Although the absence
of Ser-23 in dog and pig enzyme shows that PKC may not have a major
role in direct phosphorylation of the sodium pump in vivo in these
species, as mentioned earlier, phosphorylation of Ser-23 appears to be
an important mechanism by which PKC modulates the rat kidney enzyme.
Other experiments supporting this conclusion include recent studies
showing that neither a Ser-23
Ala mutant transfected into COS cells
(27) nor a deletion mutant lacking the first 31 amino
acids transfected into OK cells (267) is modulated by PKC
activators, even though the wild-type enzyme is affected in both
systems. Other experiments have shown that inhibition of the rat
1-enzyme by phosphorylation of Ser-23 is due to a shift
in the conformational equilibrium toward E1, leading to a
decreased apparent affinity for K+ (212). In
experiments on the B. marinus enzyme transfected in COS-7
cells, Féraille and co-workers (108) have recently
shown that PKC-dependent phosphorylation of the pump at Ser-16 results in a stimulatory effect that is attributable to an increase in the
affinity of the enzyme for Na+ (108). In
addition, direct phosphorylation of the sodium pump is the proposed
mechanism of action of PKC in rat choroid plexus (122),
aorta (196), and nerves (50).
The foregoing results notwithstanding, the physiological relevance of
direct phosphorylation of the pump by PKC in regulating the
Na+-K+-ATPase has recently been questioned.
Thus a PKC-mediated decrease in plasma membrane sodium pumps of A6
cells transfected with the B. marinus enzyme is not
associated with phosphorylation of residues 15 and 16 (31). Consistent with this are the observations that 1) a deletion mutant of the rat 1-enzyme
lacking the first 32 amino acids was inhibited by PKC activators to the
same extent as the wild-type enzyme (247) and
2) phosphorylation of Ser-23 by activators of PKC in a rat
kidney cell line, NRK-52E, had no effect on either maximum velocity or
apparent Na+ affinity of the
Na+-K+-ATPase (117).
These experiments represent unequivocal evidence that direct
phosphorylation of the sodium pump by PKC, at least at the
NH2 terminus, cannot explain many of the PKC-mediated
effects on the enzyme and that other mechanisms must be involved,
especially in species such as the dog and pig, where Ser-23 is absent.
Indeed, there is considerable evidence for PKC-dependent mechanisms of Na+-K+-ATPase regulation independent of pump
phosphorylation. One mechanism involving stimulation of the pump
secondary to increases in cytoplasmic Na+ via the
Na+/H+ exchanger has been suggested to result
in activation of the pump in cultured ciliary epithelial cells
(232) as well as kidney proximal tubules
(38). Another plausible mechanism of PKC-mediated stimulation, without direct phosphorylation, involves stimulation by
PKC of the PLA2 pathway. As described below,
PLA2 produces arachidonic acid, whose metabolites, the
eicosanoids, can have highly specific effects on the sodium pump.
PLA2-mediated PKC regulation has been observed not only in
kidney proximal tubules (257), as already mentioned, but
also in vascular smooth muscle cells (351), transfected
COS-7 cells (108), and pancreatic
-cells (261). In the latter case, however, both
PLA2-specific effects and PKC-mediated phosphorylation of
the sodium pump were reported, suggesting that the two mechanisms may
act in concert to inhibit Na+-K+-ATPase
activity. Such a model is compatible with the observed dual mechanism
of PKC-mediated pump inhibition in proximal tubules (for example, see
Refs. 78, 257). Another mechanism of PKC-mediated regulation of the
sodium pump has been recently described. Nemoto and co-workers
(246) showed that PKC-dependent mechanisms mediate the
serum-induced increase in
1-subunit mRNA in vascular
smooth muscle cells, which implies a role of PKC in long-term
regulation of the sodium pump.
Effects of PKC on the sodium pump are not restricted to the
1-isoform. For example, PKC-dependent inhibition of the
rat
1-,
2-, and
3-isoforms
has been described in transfected HeLa cells (247) as well
as Sf-9 cells (43). In the latter system, direct phosphorylation of the
-isoforms was observed. In those studies, differences in the extents of inhibition of the different isoforms were
not detected. However, more recent work suggests that, like PKA, PKC
can affect enzyme activity in an isoform-specific fashion. Thus, in
experiments with guinea pig ventricular myocytes, PKC-dependent effects
were shown to modulate
2 but not
1 pumps
(133), whereas in experiments with frog mucociliary cells,
PKC effected almost complete inhibition of the ouabain-sensitive
activity without a change in the ouabain resistant activity, also
suggesting isoform-specific effects (138).
PKG
cGMP-dependent protein kinase (PKG) is another kinase that appears to have highly specific effects on the Na+-K+-ATPase. In a mechanism similar to the one involved in PKA activation, PKG is activated by cGMP, the cytoplasmic concentration of which is regulated by synthesis by guanylate cyclase, and degradation by cGMP phosphodiesterase (reviewed in Ref. 334). Increases in cGMP have been shown to inhibit the Na+-K+-ATPase in colon (299), skeletal muscle (206), brain (273), cultured alveolar cells (146), and infected Sf-9 cells (43). Conversely, cGMP is involved in activation of the enzyme in duck salt gland (311), mammalian aorta and arteries (115), pulmonary arterial smooth muscle (322), ciliary epithelium (65), Purkinje neurons (244), and NB-OK-1 cells (91). In the kidney, cGMP and PKG have been shown to inhibit (26, 319, 360) or stimulate (225, 295) the Na+-K+-ATPase. Although the basis for these conflicting results is unknown, the effects of cGMP/PKG are sometimes antagonistic to those of cAMP/PKA as, for example, in ciliary epithelium (65), rat skeletal muscle (206), and hamster sperm (239). The mechanism of PKG-activation appears to involve activation of guanylate cyclase by nitric oxide (NO). For example, there are reports that increases in NO via hormonal activation or incubation with NO donors such as sodium nitroprusside increase cGMP levels in cultured vascular smooth muscle cells (147), aorta and arteries (115), brain (273), renal proximal tubules (360), and alveolar cells (146). In intact cells, NO-stimulated cGMP synthesis is mediated by the neurotransmitters acetylcholine (225) and glutamate (244) as well as by atrial natriuretic peptide (26, 225, 295). Whether PKG regulates the pump through secondary modulators or by direct phosphorylation of the pump is unknown, although in one system cGMP appears to stimulate the sodium pump indirectly by increasing Na+ influx via the Na+-K+-ClIsoform-specific effects of PKG on the
Na+-K+-ATPase have also been observed.
Thus PKG modulates Na+-K+-ATPase activity of
3- but not
1-isoform in Purkinje neurons (244),
1- but not
2- or
3-isoform in brain endothelial cells (273),
and
1- and
3- but not
2-isoform in infected Sf-9 cells (43).
Tyrosine Kinases
In addition to the serine/threonine kinases mentioned above, tyrosine kinases have been shown to mediate Na+-K+-ATPase activity. Specifically, tyrosine kinases appear to have a role in the stimulatory effects of insulin and epithelial growth factor in kidney proximal tubules (112). Recent experiments on transfected OK cells have shown that the mechanism of stimulation involves direct phosphorylation of Tyr-10 of the rat enzyme (110).Protein Phosphatases
Many of the effects of protein kinases on the Na+-K+-ATPase can be reversed by protein phosphatases. Regulation of the sodium pump by the antagonistic actions of protein kinases and phosphatases has been studied extensively in the kidney and brain (reviewed in Ref. 126; see also Refs. 121, 204) and has also been observed in skeletal muscle (218) and ventricular myocytes (132). The major participants in protein phosphatase-dependent modulation of the Na+-K+-ATPase are PP1 and PP2B.The role of PP1 in countering the effects of protein kinases is thought
to represent an important mechanism of pump inhibition by dopamine
through the DA1 receptor and isoproterenol via the -adrenergic receptor. Such inhibition is mediated in part by the
activation of the PP1 inhibitors DARPP-32 and inhibitor-1 (I1) (see,
for example, Refs. 10, 121). Thus it has been shown that the increase
in cAMP levels mediated by dopamine or isoproterenol in kidney and
brain leads to phosphorylation of DARPP-32, which in turn becomes a
potent inhibitor of PP1 (9, 121,
227). Therefore, the inhibition of
Na+-K+-ATPase activity by stimulation of PKA in
these two organs involves the synergistic effects of 1)
direct phosphorylation of the enzyme by protein kinases and
2) inhibition of PP1 by DARPP-32 and I1 (8,
121). Although DARPP-32 is involved in sodium pump
regulation in most parts of the kidney and in brain, its low expression
in renal PCT precludes such a role in this segment of the nephron (308). In addition to its role in regulating the kidney
enzyme, inhibition of PP1 activity by okadaic acid or calyculin A has been shown to affect Na+-K+-ATPase activity in
ventricular myocytes (132) and both pump activity and
phosphorylation level in the rat skeletal muscle cell line L6
(275).
The physiological role of PP2B, or calcineurin, in the kidney has
recently been reviewed (331). It is a Ca2+-
and calmodulin-dependent enzyme that, upon activation by norepinephrine and -adrenergic receptor agonists, activates the
Na+-K+-ATPase of most segments of the nephron
(201), although its main effects are on the enzyme of PCT
(12). Other activators of calcineurin in the kidney
include neuropeptide Y and the connecting peptide of proinsulin,
C-peptide (253). It has also been suggested that the role
of calcineurin in the kidney is to counter dopamine-induced inhibition
of the Na+-K+-ATPase and that it does this by
dephosphorylating targets of dopamine-stimulated protein kinases
(8). It has been suggested that calcineurin mediates its
stimulatory effects at least in part by increasing the apparent
affinity of the sodium pump for Na+ (12). In
addition to its role in the kidney, calcineurin mediates ouabain-induced upregulation of surface expression of
1
1 pumps in cultured astrocytes
(163) and has a role in sodium pump activation during
glutamate toxicity in rat neurons (220) and in the
long-term upregulation of the sodium pump by aldosterone in A6 cells
(285).
Another protein phosphatase shown to modulate Na+-K+-ATPase activity is protein phosphatase 2A (PP2A), which increases pump plasma membrane expression in cortical collecting duct (46) and counters PKC-mediated inhibition of the Na+-K+-ATPase in Sf-9 infected cells (43). Paradoxically, inhibitors of PP2A stimulate the pump in hepatocytes (216). Finally, tyrosine phosphatases may also modulate Na+-K+-ATPase function in PCT (112) and liver (58), as evidenced by the stimulatory effect of vanadate ions acting as tyrosine phosphatase inhibitors.
PLA2
As discussed above, the PLA2 pathway of pump regulation can be activated by both PKA and PKC. Activated PLA2 can cleave phospholipids in the membrane to generate lysophospholipids and arachidonic acid, both of which have been shown to have specific effects on the Na+-K+-ATPase. Arachidonic acid is further metabolized in the cell by a variety of oxygenases to form eicosanoids, including prostaglandins (PG), thromboxanes (TX), and oxygenated compounds such as hydroxyeicosatetraenoic acids (HETE) and epoxyeicosatrienoic acids (EET), all of which are modulators of the Na+-K+-ATPase (293).The consequence of lysophospholipids as well as arachidonic acid and its metabolites on the Na+-K+-ATPase are generally inhibitory. Thus addition of lysophosphatidylcholine to sarcolemmal membranes of mammalian heart caused a 50% inhibition of Na+-K+-ATPase activity (180). Similarly, arachidonic acid has been shown to be one of the mediators of dopamine-induced inhibition of the sodium pump in the kidney (291). Further studies using this system revealed that the effectors of arachidonic acid-mediated inhibition are its metabolites, specifically prostaglandin E (PGE) and the various products of cytochrome P-450-dependent monooxygenase-mediated cleavage of arachidonic acid, including HETE and EET (293). In addition to effects on the renal enzyme, PG can alter Na+-K+-ATPase activity in other tissues (for examples, see Refs. 89, 184, 266). Satoh and co-workers (293) showed that PGE inhibits the pump by decreasing intracellular Na+, whereas HETE and EET have direct effects on the sodium pump. The precise mechanism whereby eicosanoids inhibit sodium pump activity is unknown.
In addition to acting directly on the sodium pump, eicosanoids have
also been shown to stimulate protein kinases, resulting in modulation
of the pump via mechanisms described above. For example, PG modulates
cAMP levels, thereby affecting sodium pump activity in several
mammalian tissues and cells, including small intestine
(303), smooth muscle (337), nerves
(355), macrophages (53), and MDCK cells
(323). Recently, a role of PKC in eicosanoid-mediated sodium pump regulation was also observed in rat
1-transfected COS cells (250) and
pancreatic
-cells (261).
![]() |
CONCLUSIONS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The need for the ubiquitous Na+-K+-ATPase
to adapt to the diverse needs of different tissues underscores the
importance of mechanisms for regulating its activity. The signaling
cascades involved in hormonal regulation, in particular, are varied and
complex. Alterations in activity may be the result of posttranslational
modification such as phosphorylation. It remains to be determined
whether and to what extent such modifications affect the
Na+-K+-ATPase -subunit, per se, or some
regulatory component. An added complexity is the question of whether
various kinase isoforms such as those of PKC can have differential
effects on sodium pump activity, offering a possible explanation for
differences in regulation in various tissues and of the various pump isoforms.
In certain instances, alterations in Na+-K+-ATPase activity and kinetic behavior result from specific interaction with other membrane components. These include proteins intrinsic to the plasma membrane as well as those of the cytoskeleton. Such interactions are clearly tissue specific, and studies of the nature and mechanism of regulation by these components are a current topical and exciting area of investigation.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Prof. Anita Aperia, Karolinska Institutet, Stockholm, Sweden, for very helpful comments on the manuscript.
![]() |
FOOTNOTES |
---|
The original work from the authors' laboratories was supported by Medical Research Council of Canada Grant MT-3876, Quebec Heart and Stroke Foundation Grant 209924, and a predoctoral fellowship to A. G. Therien from the Fonds pour la Formation de Chercheurs et d'Aide à la Recherche.
Present address of A. G. Therien: Hospital for Sick Children, Division of Structural Biology and Biochemistry, Toronto, Ontario, Canada, M9A 4M6.
Address for reprint requests and other correspondence: R. Blostein, Montreal General Hospital, 1650 Cedar Ave., Rm. L11-132, Montreal, Quebec, Canada H3G 1A4 (E-mail: mirb{at}musica.mcgill.ca).
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Abdulnour-Nakhoul, S,
Khuri RN,
and
Nakhoul NL.
Effect of norepinephrine on cellular sodium transport in Ambystoma kidney proximal tubule.
Am J Physiol Renal Fluid Electrolyte Physiol
267:
F725-736,
1994
2.
Aceves, J.
Sodium pump stimulation by oxytocin and cyclic AMP in the isolated epithelium of the frog skin.
Pflügers Arch
371:
211-216,
1977[ISI][Medline].
3.
Ahmad, M,
and
Medford RM.
Evidence for the regulation of Na+,K+-ATPase gene expression through the interaction of aldosterone and cAMP-inducible transcriptional factors.
Steroids
60:
147-152,
1995[ISI][Medline].
4.
Aizman, O,
Brisman H,
Uhlén P,
Zettergren E,
Levey AI,
Forssberg H,
Greengard P,
and
Aperia A.
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons.
Nat Neurosci
3:
226-230,
2000[ISI][Medline].
5.
Andersson, RM,
Cheng SXJ,
and
Aperia A.
Forskolin-induced down-regulation of Na+,K+-ATPase activity is not associated with internalization of the enzyme.
Acta Physiol Scand
164:
39-46,
1998[ISI][Medline].
6.
Aperia, A.
Dopamine action and metabolism in the kidney.
Curr Opin Nephrol Hypertens
3:
39-45,
1994[Medline].
7.
Aperia, A,
Bertorello A,
and
Seri I.
Dopamine causes inhibition of Na+-K+-ATPase activity in rat proximal convoluted tubule segments.
Am J Physiol Renal Fluid Electrolyte Physiol
252:
F39-F45,
1987
8.
Aperia, A,
Fryckstedt J,
Holtback U,
Belusa R,
Cheng XJ,
Eklof AC,
Li D,
Wang ZM,
and
Ohtomo Y.
Cellular mechanisms for bi-directional regulation of tubular sodium reabsorption.
Kidney Int
49:
1743-1747,
1996[ISI][Medline].
9.
Aperia, A,
Fryckstedt S,
Svensson L,
Hemmings HCJ,
Nairn AC,
and
Greengard P.
Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K+-ATPase activity in renal tubule cells.
Proc Natl Acad Sci USA
88:
2798-2801,
1991[Abstract].
10.
Aperia, A,
Hökfelt T,
Meister B,
Bertorello A,
Fryckstedt J,
Holtback U,
and
Seri I.
The significance of L-amino acid decarboxylase and DARPP-32 in the kidney.
Am J Hypertens
3:
11S-13S,
1990[Medline].
11.
Aperia, A,
Holtback U,
Syren ML,
Svensson LB,
Fryckstedt J,
and
Greengard P.
Activation/deactivation of renal Na+,K+-ATPase: a final common pathway for regulation of natriuresis.
FASEB J
8:
436-439,
1994
12.
Aperia, A,
Ibarra F,
Svensson LB,
Klee C,
and
Greengard P.
Calcineurin mediates -adrenergic stimulation of Na+,K+-ATPase activity in renal tubule cells.
Proc Natl Acad Sci USA
89:
7394-7397,
1992[Abstract].
13.
Arystarkhova, E,
Wetzel RK,
Asinovski NK,
and
Sweadner KJ.
The subunit modulates Na+ and K+ affinity of the renal Na,K-ATPase.
J Biol Chem
274:
33183-33185,
1999
14.
Attali, B,
Latter H,
Rachamim N,
and
Garty H.
A corticosteroid-induced gene expressing an "IsK-like" K+ channel activity in Xenopus oocytes.
Proc Natl Acad Sci USA
92:
6092-6096,
1995
15.
Aw, TY,
and
Jones DP.
ATP concentration gradients in cytosol of liver cells during hypoxia.
Am J Physiol Cell Physiol
249:
C385-C392,
1985[Abstract].
16.
Baines, AD,
Ho P,
and
Drangova R.
Proximal tubular dopamine production regulates basolateral Na-K-ATPase.
Am J Physiol Renal Fluid Electrolyte Physiol
262:
F566-F571,
1992
17.
Bandman, O,
and
Goli SK.
cDNA encoding a human phospholemman-like protein (HPLP). GenBank accession no. AAC88077, 1998.
18.
Barlet-Bas, C,
Khadouri C,
Marsy S,
and
Doucet A.
Sodium-independent in vitro induction of Na+,K+-ATPase by aldosterone in renal target cells: permissive effect of triiodothyronine.
Proc Natl Acad Sci USA
85:
1707-1711,
1988[Abstract].
19.
Barnard, ML,
Olivera WG,
Rutschman DM,
Bertorello AM,
Katz AI,
and
Sznajder JI.
Dopamine stimulates sodium transport and liquid clearance in rat lung epithelium.
Am J Respir Crit Care Med
156:
709-714,
1997
20.
Beach, RE,
Schwab SJ,
Brazy PC,
and
Dennis VW.
Norepinephrine increases Na+-K+-ATPase and solute transport in rabbit proximal tubules.
Am J Physiol Renal Fluid Electrolyte Physiol
252:
F215-F220,
1987
21.
Beck, JS,
Marsolais M,
Noel J,
Breton S,
and
Laprade R.
Dibutyryl cyclic adenosine monophosphate stimulates the sodium pump in rabbit renal cortical tubules.
Renal Physiol Biochem
18:
21-26,
1995[ISI][Medline].
22.
Beebe, SJ.
The cAMP-dependent protein kinases and cAMP signal transduction.
Semin Cancer Biol
5:
285-294,
1994[ISI][Medline].
23.
Béguin, P,
Beggah A,
Cotecchia S,
and
Geering K.
Adrenergic, dopaminergic, and muscarinic receptor stimulation leads to PKA phosphorylation of Na-K-ATPase.
Am J Physiol Cell Physiol
270:
C131-C137,
1996
24.
Béguin, P,
Beggah AT,
Chibalin AV,
Burgener-Kairuz P,
Jaisser F,
Mathews PM,
Rossier BC,
Cotecchia S,
and
Geering K.
Phosphorylation of the Na,K-ATPase -subunit by protein kinase A and C in vitro and in intact cells. Identification of a novel motif for PKC-mediated phosphorylation.
J Biol Chem
269:
24437-24445,
1994
25.
Béguin, P,
Wang X,
Firsov D,
Puoti A,
Claeys D,
Horisberger JD,
and
Geering K.
The subunit is a specific component of the Na,K-ATPase and modulates its transport function.
EMBO J
16:
4250-4260,
1997
26.
Beltowski, J,
Gorny D,
and
Marciniak A.
The mechanism of Na+,K+-ATPase inhibition by atrial natriuretic factor in rat renal medulla.
J Physiol Pharmacol
49:
271-283,
1998[ISI][Medline].
27.
Belusa, R,
Wang ZM,
Matsubara T,
Sahlgren B,
Dulubova I,
Nairn AC,
Ruoslahti E,
Greengard P,
and
Aperia A.
Mutation of the protein kinase C phosphorylation site on rat Na+,K+-ATPase alters regulation of intracellular Na+ and pH and influences cell shape and adhesiveness.
J Biol Chem
272:
20179-20184,
1997
28.
Beron, J,
Forster I,
Béguin P,
Geering K,
and
Verrey F.
Phorbol 12-myristate 13-acetate down-regulates Na,K-ATPase independent of its protein kinase C site: decrease in basolateral cell surface area.
Mol Biol Cell
8:
387-398,
1997[Abstract].
29.
Beron, J,
Mastroberardino L,
Spillmann A,
and
Verrey F.
Aldosterone modulates sodium kinetics of Na,K-ATPase containing an subunit in A6 kidney cell epithelia.
Mol Biol Cell
6:
261-271,
1995[Abstract].
30.
Beron, J,
and
Verrey F.
Aldosterone induces early activation and late accumulation of Na-K-ATPase at surface of A6 cells.
Am J Physiol Cell Physiol
266:
C1278-C1290,
1994
31.
Beron, J,
and
Verrey F.
Phosphorylation site-independent downregulation of Na-pump current in A6 epithelia by protein kinase C. Decrease in Na,K-ATPase cell-surface expression.
Ann NY Acad Sci
834:
569-571,
1997[ISI][Medline].
32.
Bertorello, A,
and
Aperia A.
Inhibition of proximal tubule Na+-K+-ATPase activity requires simultaneous activation of DA1 and DA2 receptors.
Am J Physiol Renal Fluid Electrolyte Physiol
259:
F924-F928,
1990
33.
Bertorello, A,
and
Aperia A.
Na+-K+-ATPase is an effector protein for protein kinase C in renal proximal tubule cells.
Am J Physiol Renal Fluid Electrolyte Physiol
256:
F370-F373,
1989
34.
Bertorello, A,
and
Aperia A.
Regulation of Na+-K+-ATPase activity in kidney proximal tubules: involvement of GTP binding proteins.
Am J Physiol Renal Fluid Electrolyte Physiol
256:
F57-F62,
1989
35.
Bertorello, A,
and
Aperia A.
Short-term regulation of Na+,K+-ATPase activity by dopamine.
Am J Hypertens
3:
51S-54S,
1990[Medline].
36.
Bertorello, A,
Hökfelt T,
Goldstein M,
and
Aperia A.
Proximal tubule Na+-K+-ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect.
Am J Physiol Renal Fluid Electrolyte Physiol
254:
F795-F801,
1988
37.
Bertorello, A,
Hopfield JF,
Aperia A,
and
Greengard P.
Inhibition by dopamine of (Na++K+) ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism.
Nature
347:
386-388,
1990[ISI][Medline].
38.
Bertorello, AM.
Diacylglycerol activation of protein kinase C results in a dual effect on Na+,K+-ATPase activity from intact renal proximal tubule cells.
J Cell Sci
101:
343-347,
1992[Abstract].
39.
Bertorello, AM,
Aperia A,
Walaas SI,
Nairn AC,
and
Greengard P.
Phosphorylation of the catalytic subunit of Na+,K+-ATPase inhibits the activity of the enzyme.
Proc Natl Acad Sci USA
88:
11359-11362,
1991[Abstract].
40.
Bertorello, AM,
Ridge KM,
Chibalin AV,
Katz AI,
and
Sznajder JI.
Isoproterenol increases Na+-K+-ATPase activity by membrane insertion of -subunits in lung alveolar cells.
Am J Physiol Lung Cell Mol Physiol
276:
L20-L27,
1999
41.
Bhutada, A,
Wassynger WW,
and
Ismail-Beigi F.
Dexamethasone markedly induces Na,K-ATPase mRNA in a rat liver cell line.
J Biol Chem
266:
10859-10866,
1991
42.
Blanco, G,
and
Mercer RW.
Isozymes of the Na,K-ATPase: heterogeneity in structure, diversity in function.
Am J Physiol Renal Physiol
275:
F633-F650,
1998
43.
Blanco, G,
Sanchez G,
and
Mercer RW.
Differential regulation of Na,K-ATPase isozymes by protein kinases and arachidonic acid.
Arch Biochem Biophys
359:
139-150,
1998[ISI][Medline].
44.
Blaustein, MP.
Endogenous ouabain: role in the pathogenesis of hypertension.
Kidney Int
49:
1748-1753,
1996[ISI][Medline].
45.
Blaustein, MP.
Sodium ions, calcium ions and blood pressure regulation, and hypertension: a reassessment and a hypothesis.
Am J Physiol Cell Physiol
232:
C165-C173,
1977[Abstract].
46.
Blot-Chabaud, M,
Coutry N,
Laplace M,
Bonvalet J,
and
Farman N.
Role of protein phosphatase in the regulation of Na+-K+-ATPase by vasopressin in the cortical collecting duct.
J Membr Biol
153:
233-239,
1996[ISI][Medline].
47.
Blot-Chabaud, M,
Wanstok F,
Bonvalet JP,
and
Farman N.
Cell sodium-induced recruitment of Na+-K+-ATPase pumps in rabbit cortical collecting tubules is aldosterone-dependent.
J Biol Chem
265:
11676-11681,
1990
48.
Bogaev, RC,
Kobayashi YM,
Mounsey JP,
Moorman JR,
Jones LR,
and
Tucker AL.
Gene structure and expression of phospholemman in mouse. GenBank accession no. AAD11781, 1998.
49.
Bonvalet, JP.
Regulation of sodium transport by steroid hormones.
Kidney Int Suppl
65:
S49-S56,
1998[Medline].
50.
Borghini, I,
Geering K,
Gjinovci A,
Wollheim CB,
and
Pralong WF.
In vivo phosphorylation of the Na,K-ATPase subunit in sciatic nerves of control and diabetic rats: effects of protein kinase modulators.
Proc Natl Acad Sci USA
91:
6211-6215,
1994[Abstract].
51.
Borin, ML.
Roles of PKA and PKC in regulation of Na+ pump activity in vascular smooth muscle cells.
Ann NY Acad Sci
834:
576-578,
1997[ISI][Medline].
52.
Bradford, NM,
Hayes MR,
and
McGivan JD.
The use of 36Cl to measure cell plasma membrane potential in isolated hepatocytes
effects of cyclic AMP and bicarbonate ions.
Biochim Biophys Acta
845:
10-16,
1985[ISI][Medline].
53.
Braquet, P,
Diez J,
and
Garay R.
Ion transport regulation by prostaglandins in mouse macrophages.
Int J Tissue React
7:
303-308,
1985[ISI][Medline].
54.
Braughler, JM,
and
Corder CN.
Reversible in activation of purified (Na+ + K+)-ATPase from human renal tissue by cyclic AMP-dependent protein kinase.
Biochim Biophys Acta
524:
455-465,
1978[ISI][Medline].
55.
Breton, S,
Beck JS,
and
Laprade R.
cAMP stimulates proximal convoluted tubule Na+-K+-ATPase activity.
Am J Physiol Renal Fluid Electrolyte Physiol
266:
F400-F410,
1994
56.
Brezis, M,
and
Rosen S.
Hypoxia of the renal medullaits implications for disease.
N Engl J Med
332:
647-655,
1995
57.
Brodsky, JL.
Characterization of the (Na+ + K+)-ATPase from 3T3-F442A fibroblasts and adipocytes. Isozymes and insulin sensitivity.
J Biol Chem
265:
10458-10465,
1990
58.
Bruck, R,
Halpern Z,
Aeed H,
Shechter Y,
and
Karlish SJD
Vanadyl ions stimulate K+ uptake into isolated perfused rat liver via the Na+/K+-pump by a tyrosine kinase-dependent mechanism.
Pflügers Arch
435:
610-616,
1998[ISI][Medline].
59.
Buhagiar, KA,
Hansen PS,
Gray DF,
Mihailidou AS,
and
Rasmussen HH.
Angiotensin regulates the selectivity of the Na+-K+ pump for intracellular Na+.
Am J Physiol Cell Physiol
277:
C461-C468,
1999
60.
Cantiello, HF.
Actin filaments stimulate the Na+-K+-ATPase.
Am J Physiol Renal Fluid Electrolyte Physiol
269:
F637-F643,
1995
61.
Cantiello, HF.
Changes in actin filament organization regulate Na+,K+-ATPase activity. Role of actin phosphorylation.
Ann NY Acad Sci
834:
559-561,
1997[ISI][Medline].
62.
Carranza, ML,
Féraille E,
and
Favre H.
Protein kinase C-dependent phosphorylation of Na+-K+-ATPase -subunit in rat kidney cortical tubules.
Am J Physiol Cell Physiol
271:
C136-C143,
1996
63.
Carranza, ML,
Féraille E,
Kiroytcheva M,
Rousselot M,
and
Favre H.
Stimulation of ouabain-sensitive 86Rb+ uptake and Na+,K+-ATPase -subunit phosphorylation by a cAMP-dependent signalling pathway in intact cells from rat kidney cortex.
FEBS Lett
396:
309-314,
1996[ISI][Medline].
64.
Carranza, ML,
Rousselot M,
Chibalin AV,
Bertorello AM,
Favre H,
and
Féraille E.
Protein kinase A induces recruitment of active Na+,K+-ATPase units to the plasma membrane of rat proximal convoluted tubule cells.
J Physiol (Lond)
511:
235-243,
1998
65.
Carre, DA,
and
Civan MM.
cGMP modulates transport across the ciliary epithelium.
J Membr Biol
146:
293-305,
1995[ISI][Medline].
66.
Castagna, M,
Takai Y,
Kaibuchi K,
Sano K,
Kikkawa U,
and
Nishizuka Y.
Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.
J Biol Chem
257:
7847-7851,
1982
67.
Catarsi, S,
Scuri R,
and
Brunelli M.
Cyclic AMP mediates inhibition of the Na+-K+ electrogenic pump by serotonin in tactile sensory neurones of the leech.
J Physiol (Lond)
462:
229-242,
1993[Abstract].
68.
Celsi, G,
Wang ZM,
Akusjarvi G,
and
Aperia A.
Sensitive periods for glucocorticoids' regulation of Na+,K+-ATPase mRNA in the developing lung and kidney.
Pediatr Res
33:
5-9,
1993[Abstract].
69.
Chapman, GE,
and
Greenwood CE.
Stimulation of brain Na,K-ATPase by norepinephrine but not taurine.
Neurochem Res
13:
77-82,
1988[ISI][Medline].
70.
Charles, A,
Dawicki DD,
Oldmixon E,
Kuhn C,
Cutaia M,
and
Rounds S.
Studies on the mechanism of short-term regulation of pulmonary artery endothelial cell Na/K pump activity.
J Lab Clin Med
130:
157-168,
1997[ISI][Medline].
71.
Chen, C,
Beach RE,
and
Lokhandwala MF.
Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats.
Hypertension
21:
364-372,
1993[Abstract].
72.
Chen, LS,
Lo CF,
Numann R,
and
Cuddy M.
Characterization of the human and rat phospholemman (PLM) cDNAs and localization of the human PLM gene to chromosome 19q13.1.
Genomics
41:
435-443,
1997[ISI][Medline].
73.
Chen, Z,
Jones LR,
O'Brian JJ,
Moorman JR,
and
Cala SE.
Structural domains in phospholemman: a possible role for the carboxyl terminus in channel inactivation.
Circ Res
82:
367-374,
1998
74.
Cheng, SXJ,
Aizman O,
Nairn AC,
Greengard P,
and
Aperia P.
[Ca2+]i determines the effects of protein kinases A and C on activity of rat renal Na+,K+-ATPase.
J Physiol (Lond)
518:
37-46,
1999
75.
Cheng, XJ,
Fisone G,
Aizman O,
Aizman R,
Levenson R,
Greengard P,
and
Aperia A.
PKA-mediated phosphorylation and inhibition of Na+-K+-ATPase in response to -adrenergic hormone.
Am J Physiol Cell Physiol
273:
C893-C901,
1997
76.
Cheng, XJ,
Hoog JO,
Nairn AC,
Greengard P,
and
Aperia A.
Regulation of rat Na+-K+-ATPase activity by PKC is modulated by state of phosphorylation of Ser-943 by PKA.
Am J Physiol Cell Physiol
273:
C1981-C1986,
1997
77.
Chibalin, AV,
Katz AI,
Berggren PO,
and
Bertorello AM.
Receptor-mediated inhibition of renal Na+-K+-ATPase is associated with endocytosis of its - and
-subunits.
Am J Physiol Cell Physiol
273:
C1458-C1465,
1997
78.
Chibalin, AV,
Ogimoto G,
Pedemonte CH,
Pressley TA,
Katz AI,
Féraille E,
Berggren PO,
and
Bertorello AM.
Dopamine-induced endocytosis of Na+,K+-ATPase is initiated by phosphorylation of Ser-18 in the rat subunit and is responsible for the decreased activity in epithelial cells.
J Biol Chem
274:
1920-1927,
1999
79.
Chibalin, AV,
Pedemonte CH,
Katz AI,
Féraille E,
Berggren PO,
and
Bertorello AM.
Phosphorylation of the catalytic -subunit constitutes a triggering signal for Na+,K+-ATPase endocytosis.
J Biol Chem
273:
8814-8819,
1998
80.
Chibalin, AV,
Vasilets LA,
Hennekes H,
Pralong D,
and
Geering K.
Phosphorylation of Na,K-ATPase -subunits in microsomes and in homogenates of Xenopus oocytes resulting from the stimulation of protein kinase A and protein kinase C.
J Biol Chem
267:
22378-22384,
1992
81.
Chou, SY,
Porush JG,
and
Faubert PF.
Renal medullary circulation: hormonal control.
Kidney Int
37:
1-13,
1990[ISI][Medline].
82.
Clausen, T.
The Na+,K+ pump in skeletal muscle: quantification, regulation and functional significance.
Acta Physiol Scand
156:
227-235,
1996[ISI][Medline].
83.
Clausen, T,
and
Flatman JA.
Effects of insulin and epinephrine on Na+-K+ and glucose transport in soleus muscle.
Am J Physiol Endocrinol Metab
252:
E492-E499,
1987
84.
Clausen, T,
and
Nielsen OB.
The Na+,K+-pump and muscle contractility.
Acta Physiol Scand
152:
365-573,
1994[ISI][Medline].
85.
Collins, JH,
Forbush B, III,
Lane LK,
Ling E,
Schwartz A,
and
Zot A.
Purification and characterization of an (Na+ + K+)-ATPase proteolipid labeled with a photoaffinity derivative of ouabain.
Biochim Biophys Acta
686:
7-12,
1982[ISI][Medline].
86.
Cook, LS,
Straub KD,
Doherty JE,
Whittle JL,
and
Baker BJ.
Digitalis-sensitive Na+,K+-ATPase: lack of a direct catecholamine-mediated stimulation in bovine myocardial tissue.
J Cardiovasc Pharmacol
5:
446-449,
1983[ISI][Medline].
87.
Cornelius, F,
and
Logvinenko N.
Functional regulation of reconstituted Na,K-ATPase by protein kinase A phosphorylation.
FEBS Lett
380:
277-280,
1996[ISI][Medline].
88.
Delamere, NA,
and
King KL.
The influence of cyclic AMP upon Na,K-ATPase activity in rabbit ciliary epithelium.
Invest Ophthalmol Vis Sci
33:
430-435,
1992[Abstract].
89.
Delamere, NA,
Parkerson J,
and
Hou Y.
Indomethacin alters the Na,K-ATPase response to protein kinase C activation in cultured rabbit nonpigmented ciliary epithelium.
Invest Ophthalmol Vis Sci
38:
866-875,
1997[Abstract].
90.
Delbono, O,
and
Kotsias BA.
Hyperpolarizing effect of aminophylline, theophylline, and cAMP on rat diaphragm fibers.
J Appl Physiol
64:
1893-1899,
1988
91.
Delporte, C,
Winand J,
Poloczek P,
and
Christophe J.
Regulation of Na-K-Cl cotransport, Na,K-adenosine triphosphatase, and Na/H exchanger in human neuroblastoma NB-OK-1 cells by atrial natriuretic peptide.
Endocrinology
133:
77-82,
1993[Abstract].
92.
Derfoul, A,
Robertson NM,
Lingrel JB,
Hall DJ,
and
Litwack G.
Regulation of the human Na/K-ATPase gene promoter by mineralocorticoid and glucocorticoid receptors.
J Biol Chem
273:
20702-20711,
1998
93.
Derrickson, BH,
and
Mandel LJ.
Parathyroid hormone inhibits Na+-K+-ATPase through Gq/G11 and the calcium-independent phospholipase A2.
Am J Physiol Renal Physiol
272:
F781-F788,
1997
94.
Désilets, M,
and
Baumgarten CM.
Isoproterenol directly stimulates the Na+-K+ pump in isolated cardiac myocytes.
Am J Physiol Heart Circ Physiol
251:
H218-H225,
1986[ISI][Medline].
95.
DeTomasso, AW,
Xie ZJ,
Liu G,
and
Mercer RW.
Expression, targeting and assembly of functional Na,K-ATPase polypeptides in baculovirus-infected insect cells.
J Biol Chem
268:
1470-1478,
1993
96.
Devarajan, P,
Scaramuzzino DA,
and
Morrow JS.
Ankyrin binds two distinct cytoplasmic domains of Na,K-ATPase subunit.
Proc Natl Acad Sci USA
91:
2965-2969,
1994[Abstract].
97.
Devarajan, P,
Stabach PR,
De Matteis MA,
and
Morrow JS.
Na,K-ATPase transport from endoplasmic reticulum to Golgi requires the Golgi spectrin-ankyrin G119 skeleton in Madin Darby canine kidney cells.
Proc Natl Acad Sci USA
94:
10711-10716,
1997
98.
Diez, J,
Braquet P,
Verna R,
Nazaret C,
and
Garay RP.
The effect of cyclic AMP on Na+ and K+ transport systems in mouse macrophages.
Experientia
41:
666-667,
1985[ISI][Medline].
99.
Doris, PA,
and
Bagrov AY.
Endogenous sodium pump inhibitors and blood pressure regulation: an update on recent progress.
Proc Soc Exp Biol Med
218:
156-167,
1998[Abstract].
100.
Dorup, I,
and
Clausen T.
Effects of adrenal steroids on the concentration of Na+-K+ pumps in rat skeletal muscle.
J Endocrinol
152:
49-57,
1997[Abstract].
101.
Doucet, A.
Function and control of Na-K-ATPase in single nephron segments of the mammalian kidney.
Kidney Int
34:
749-760,
1988[ISI][Medline].
102.
Dunham, P,
and
Anderson C.
On the mechanism of stimulation of the Na/K pump of LK sheep erythrocytes by anti-L antibody.
J Gen Physiol
90:
3-25,
1987[Abstract].
103.
Dunham, PB,
and
Blostein R.
L antigens of sheep red blood cell membranes and modulation of ion transport.
Am J Physiol Cell Physiol
272:
C357-C368,
1997
104.
Ellory, JC,
and
Tucker EM.
Stimulation of the potassium transport system in low potassium type sheep red cells by a specific antigen antibody reaction.
Nature
222:
477-478,
1969[ISI][Medline].
105.
Efendiev, R,
Bertorello AM,
and
Pedemonte CH.
PKC- and PKC-
mediate opposing effects on proximal tubule Na+,K+-ATPase activity.
FEBS Lett
456:
45-48,
1999[ISI][Medline].
106.
Ewart, HS,
and
Klip A.
Hormonal regulation of the Na+,K+-ATPase: mechanisms underlying rapid and sustained changes in pump activity.
Am J Physiol Cell Physiol
269:
C295-C311,
1995
107.
Farman, N,
Bonvalet JP,
and
Seckl JR.
Aldosterone selectively increases Na+-K+-ATPase -subunit mRNA expression in rat hippocampus.
Am J Physiol Cell Physiol
266:
C423-C428,
1994
108.
Féraille, E,
Béguin P,
Carranza ML,
Gonin S,
Rousselot M, MPY,
Favre H,
and
Geering K.
Is phosphorylation of the subunit at Ser-16 involved in the control of Na,K-ATPase activity by phorbol ester-activated protein kinase C?
Mol Biol Cell
11:
39-50,
2000
109.
Féraille, E,
Carranza ML,
Buffin-Meyer B,
Rousselot M,
Doucet A,
and
Favre H.
Protein kinase C-dependent stimulation of Na+-K+-ATPase in rat proximal convoluted tubules.
Am J Physiol Cell Physiol
268:
C1277-C1283,
1995
110.
Féraille, E,
Carranza ML,
Gonin S,
Béguin P,
Pedemonte C,
Rousselot M,
Caverzasio J,
Geering K,
Martin PY,
and
Favre H.
Insulin-induced stimulation of Na+,K+-ATPase activity in kidney proximal tubule cells depends on phosphorylation of the -subunit at Tyr-10.
Mol Biol Cell
10:
2847-2859,
1999
111.
Féraille, E,
Carranza ML,
Rousselot M,
and
Favre H.
Insulin enhances sodium sensitivity of Na-K-ATPase in isolated rat proximal convoluted tubule.
Am J Physiol Renal Fluid Electrolyte Physiol
267:
F55-F62,
1994
112.
Féraille, E,
Carranza ML,
Rousselot M,
and
Favre H.
Modulation of Na+,K+-ATPase activity by a tyrosine phosphorylation process in rat proximal convoluted tubule.
J Physiol (Lond)
498:
99-108,
1997[Abstract].
113.
Féraille, E,
Rousselot M,
Rajerison R,
and
Favre H.
Effect of insulin on Na+,K+-ATPase in rat collecting duct.
J Physiol (Lond)
488:
171-180,
1995[Abstract].
114.
Ferrandi, M,
Salardi S,
Tripodi G,
Barassi P,
Rivera R,
Manunta P,
Goldshleger R,
Ferrari P,
Bianchi G,
and
Karlish SJD
Evidence for an interaction between adducin and Na+-K+-ATPase: relation to genetic hypertension.
Am J Physiol Heart Circ Physiol
277:
H1338-H1349,
1999
115.
Ferrer, M,
Encabo A,
Conde MV,
Marin J,
and
Balfagon G.
Heterogeneity of endothelium-dependent mechanisms in different rabbit arteries.
J Vasc Res
32:
339-346,
1995[ISI][Medline].
116.
Feschenko, MS,
and
Sweadner KJ.
Conformation-dependent phosphorylation of Na,K-ATPase by protein kinase A and protein kinase C.
J Biol Chem
269:
30436-30444,
1994
117.
Feschenko, MS,
and
Sweadner KJ.
Phosphorylation of Na,K-ATPase by protein kinase C at Ser18 occurs in intact cells but does not result in direct inhibition of ATP hydrolysis.
J Biol Chem
272:
17726-17733,
1997
118.
Feschenko, MS,
and
Sweadner KJ.
Structural basis for species-specific differences in the phosphorylation of Na,K-ATPase by protein kinase C.
J Biol Chem
270:
14072-14077,
1995
119.
Feschenko, MS,
Wetzel RK,
and
Sweadner KJ.
Phosphorylation of Na,K-ATPase by protein kinases. Sites, susceptibility, and consequences.
Ann NY Acad Sci
834:
479-488,
1997[ISI][Medline].
120.
Fisone, G,
Cheng SX,
Nairn AC,
Czernik AJ,
Hemmings HC, Jr,
Hoog JO,
Bertorello AM,
Kaiser R,
Bergman T,
Jornvall H,
Identification of the phosphorylation site for cAMP-dependent protein kinase on Na+,K+-ATPase and effects of site-directed mutagenesis.
J Biol Chem
269:
9368-9373,
1994
121.
Fisone, G,
Snyder GL,
Aperia A,
and
Greengard P.
Na+,K+-ATPase phosphorylation in the choroid plexus: synergistic regulation by serotonin/protein kinase C and isoproterenol/cAMP-PK/PP-1 pathways.
Mol Med
4:
258-265,
1998[ISI][Medline].
122.
Fisone, G,
Snyder GL,
Fryckstedt J,
Caplan MJ,
Aperia A,
and
Greengard P.
Na+,K+-ATPase in the choroid plexus. Regulation by serotonin/protein kinase C pathway.
J Biol Chem
270:
2427-2430,
1995
123.
Fondacaro, JD.
Intestinal ion transport and diarrheal disease.
Am J Physiol Gastrointest Liver Physiol
250:
G1-G8,
1986[ISI][Medline].
124.
Forbush, B, III,
Kaplan JH,
and
Hoffman JF.
Characterization of a new photoaffinity derivative of ouabain: labeling of the large polypeptide and of a proteolipid component of the Na, K-ATPase.
Biochemistry
17:
3667-3676,
1978[ISI][Medline].
125.
Fryckstedt, J,
and
Aperia A.
Sodium-dependent regulation of sodium, potassium-adenosine-tri-phosphatase (Na+,K+-ATPase) activity in medullary thick ascending limb of Henle segments. Effect of cyclic-adenosine-monophosphate guanosine-nucleotide-binding-protein activity and arginine vasopressin.
Acta Physiol Scand
144:
185-190,
1992[ISI][Medline].
126.
Fryckstedt, J,
Meister B,
and
Aperia A.
Control of electrolyte transport in the kidney through a dopamine- and cAMP-regulated phosphoprotein, DARPP-32.
J Auton Pharmacol
12:
183-189,
1992[ISI][Medline].
127.
Fryckstedt, J,
Svensson LB,
Linden M,
and
Aperia A.
The effect of dopamine on adenylate cyclase an Na+,K+-ATPase activity in the developing rat renal cortical and medullary tubule cells.
Pediatr Res
34:
308-311,
1993[Abstract].
128.
Fu, X,
and
Kamps MP.
E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts.
Mol Cell Biol
17:
1503-1512,
1997[Abstract].
129.
Fujii, Y,
Takemoto F,
and
Katz AI.
Early effects of aldosterone on Na-K pump in rat cortical collecting tubules.
Am J Physiol Renal Fluid Electrolyte Physiol
259:
F40-F45,
1990
130.
Fukuda, Y,
Bertorello A,
and
Aperia A.
Ontogeny of the regulation of Na+,K+-ATPase activity in the renal proximal tubule cell.
Pediatr Res
30:
131-134,
1991[Abstract].
131.
Fuller, PJ,
and
Verity K.
Colonic sodium-potassium adenosine triphosphate subunit gene expression: ontogeny and regulation by adrenocortical steroids.
Endocrinology
127:
32-38,
1990[Abstract].
132.
Gao, J,
Cohen IS,
Mathias RT,
and
Baldo GJ.
Regulation of the -stimulation of the Na+-K+ pump current in guinea-pig ventricular myocytes by a cAMP-dependent PKA pathway.
J Physiol (Lond)
477:
373-380,
1994[Abstract].
133.
Gao, J,
Wymore R,
Wymore RT,
Wang Y,
McKinnon D,
Dixon JE,
Mathias RT,
Cohen IS,
and
Baldo GJ.
Isoform-specific regulation of the sodium pump by - and
-adrenergic agonists in the guinea-pig ventricle.
J Physiol (Lond)
516:
377-383,
1999
134.
Garay, RP,
and
Garrahan PJ.
The interaction of sodium and potassium with the sodium pump in red cells.
J Physiol (Lond)
231:
297-325,
1973[ISI][Medline].
135.
Gavryck, WA,
Moore RD,
and
Thompson RC.
Effect of insulin upon membrane-bound (Na+ + K+)-ATPase extracted from frog skeletal muscle.
J Physiol (Lond)
252:
43-58,
1975[Abstract].
136.
Geering, K,
Claire M,
Gaeggeler HP,
and
Rossier BC.
Receptor occupancy vs. induction of Na+-K+-ATPase and Na+ transport by aldosterone.
Am J Physiol Cell Physiol
248:
C102-C108,
1985
137.
Geering, K,
Girardet M,
Bron C,
Kraehenbuhl JP,
and
Rossier BC.
Hormonal regulation of (Na+,K+)-ATPase biosynthesis in the toad bladder. Effect of aldosterone and 3,5,3'-triiodo-L-thyronine.
J Biol Chem
257:
10338-10343,
1982
138.
Gertsberg, I,
Brodsky I,
Priel Z,
and
Danilenko M.
Na+-K+-ATPase in frog esophagus mucociliary cell membranes: inhibition by protein kinase C activation.
Am J Physiol Cell Physiol
273:
C1842-C1848,
1997
139.
Giesen, EM,
Imbs JL,
Grima M,
Schmidt M,
and
Schwartz J.
Modulation of renal ATPase activities by cyclic AMP.
Biochem Biophys Res Commun
120:
619-624,
1984[ISI][Medline].
140.
Giraud, F,
Claret M,
Bruckdorfer KR,
and
Chailley B.
The effects of membrane lipid order and cholesterol on the internal and external cationic sites of the Na+,K+-pump in erythrocytes.
Biochim Biophys Acta
647:
249-258,
1981[ISI][Medline].
141.
Gloor, SM.
Relevance of Na,K-ATPase to local extracellular potassium homeostasis and modulation of synaptic transmission.
FEBS Lett
412:
1-4,
1997[ISI][Medline].
142.
Goto, A,
Yamada K,
Ashii M,
Yoshioka T,
Eguchi C,
and
Sugimoto T.
Urinary sodium pump inhibitor raises cytosolic free calcium concentration in rat aorta.
Hypertension
13:
916-921,
1989[Abstract].
143.
Greene, DA,
and
Lattimer SA.
Protein kinase C agonists acutely normalize decreased ouabain-inhibitable respiration in diabetic rabbit nerve. Implications for (Na,K)-ATPase regulation and diabetic complications.
Diabetes
35:
242-245,
1986[Abstract].
144.
Grillo, C,
Piroli G,
Lima A,
McEwen BS,
and
De Nicola AF.
Aldosterone up-regulates mRNA for the and
isoforms of (Na,K)-ATPase in several brain regions from adrenalectomized rats.
Brain Res
767:
120-127,
1997[ISI][Medline].
145.
Grinstein, S,
and
Erlij D.
Insulin unmasks latent sodium pump sites in frog muscle.
Nature
251:
57-58,
1974[ISI][Medline].
146.
Guo, Y,
DuVall MD,
Crow JP,
and
Matalon S.
Nitric oxide inhibits Na+ absorption across cultured alveolar type II monolayers.
Am J Physiol Lung Cell Mol Physiol
274:
L369-L377,
1998
147.
Gupta, S,
Moreland RB,
Munarriz R,
Daley J,
Goldstein I,
and
Saenz de Tejada I.
Possible role of Na+-K+-ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide.
Br J Pharmacol
116:
2201-2206,
1995[Abstract].
148.
Gupta, S,
Ruderman NB,
Cragoe EJ, Jr,
and
Sussman I.
Endothelin stimulates Na+-K+-ATPase activity by a protein kinase C-dependent pathway in rabbit aorta.
Am J Physiol Heart Circ Physiol
261:
H38-H45,
1991
149.
Gurich, RW,
and
Beach RE.
Abnormal regulation of renal proximal tubule Na+-K+-ATPase by G proteins in spontaneously hypertensive rats.
Am J Physiol Renal Fluid Electrolyte Physiol
267:
F1069-F1075,
1994
150.
Gusev, GP,
Agalakova NI,
and
Lapin AV.
Activation of the Na+-K+ pump in frog erythrocytes by catecholamines and phosphodiesterase blockers.
Biochem Pharmacol
52:
1347-1353,
1996[ISI][Medline].
151.
Hall, C,
and
Ruoho A.
Ouabain-binding-site photoaffinity probes that label both subunits of Na+,K+-ATPase.
Proc Natl Acad Sci USA
77:
4529U-4533U,
1980.
152.
Hall, JE,
Guyton AC,
and
Brands MW.
Pressure-volume regulation in hypertension.
Kidney Int Suppl
55:
S35-S41,
1996[Medline].
153.
Hamlyn, JM,
Blaustein MP,
Bova S,
DuCharme DW,
Harris DW,
Mandel F,
Mathews WR,
and
Ludens JH.
Identification and characterization of a ouabain-like compound from human plasma.
Proc Natl Acad Sci USA
88:
6259-6263,
1991[Abstract].
154.
Hamlyn, JM,
Hamilton BP,
and
Manunta P.
Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis.
J Hypertens
14:
169-171,
1996[ISI][Medline].
155.
Hardwicke, PM,
and
Freytag JW.
A proteolipid associated with Na,K-ATPase is not essential for ATPase activity.
Biochem Biophys Res Commun
102:
250-257,
1981[ISI][Medline].
156.
Hayhurst, RA,
and
O'Neil RG.
Time-dependent actions of aldosterone and amiloride on Na+-K+-ATPase of cortical collecting duct.
Am J Physiol Renal Fluid Electrolyte Physiol
254:
F689-F696,
1988
157.
Hermenegildo, C,
Felipo V,
Minana MD,
and
Grisolia S.
Inhibition of protein kinase C restores Na+,K+-ATPase activity in sciatic nerve of diabetic mice.
J Neurochem
58:
1246-1249,
1992[ISI][Medline].
158.
Hernandez, RJ.
Na+/K+-ATPase regulation by neurotransmitters.
Neurochem Int
20:
1-10,
1992[ISI][Medline].
159.
Hilton, PJ,
White RW,
Lord GA,
Garner GV,
Gordon DB,
Hilton MJ,
and
Forni LG.
An inhibitor of the sodium pump obtained from human placenta.
Lancet
348:
303-305,
1996[ISI][Medline].
160.
Holtug, K,
Hansen MB,
and
Skadhauge E.
Experimental studies of intestinal ion and water transport.
Scand J Gastroenterol Suppl
216:
95-110,
1996[Medline].
161.
Hootman, SR,
Brown ME,
and
Williams JA.
Phorbol esters and A23187 regulate Na+-K+-pump activity in pancreatic acinar cells.
Am J Physiol Gastrointest Liver Physiol
252:
G499-G505,
1987
162.
Horwitz, BA,
and
Eaton M.
The effect of adrenergic agonists and cyclic AMP on the Na+/K+ ATPase activity of brown adipose tissue.
Eur J Pharmacol
34:
241-245,
1975[ISI][Medline].
163.
Hosoi, R,
Matsuda T,
Asano S,
Nakamura H,
Hashimoto H,
Takuma K,
and
Baba A.
Isoform-specific up-regulation by ouabain of Na+,K+-ATPase in cultured rat astrocytes.
J Neurochem
69:
2189-2196,
1997[ISI][Medline].
164.
Hughes, BA,
Miller SS,
Joseph DP,
and
Edelman JL.
cAMP stimulates the Na+-K+ pump in frog retinal pigment epithelium.
Am J Physiol Cell Physiol
254:
C84-C98,
1988
165.
Hundal, HS,
Marette A,
Mitsumoto Y,
Ramlal T,
Blostein R,
and
Klip A.
Insulin induces translocation of the and
subunits of the Na+/K+-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle.
J Biol Chem
267:
5040-5043,
1992
166.
Hussain, T,
Abdul-Wahab R,
and
Lokhandwala MF.
Bromocriptine stimulates Na+,K+-ATPase in renal proximal tubules via the cAMP pathway.
Eur J Pharmacol
321:
259-263,
1997[ISI][Medline].
167.
Hussain, T,
and
Lokhandwala MF.
Altered arachidonic acid metabolism contributes to the failure of dopamine to inhibit Na+,K+-ATPase in kidney of spontaneously hypertensive rats.
Clin Exp Hypertens
18:
963-974,
1996[ISI][Medline].
168.
Hussain, T,
and
Lokhandwala MF.
Renal dopamine receptor function in hypertension.
Hypertension
32:
187-197,
1998
169.
Ikeda, U,
Hyman R,
Smith TW,
and
Medford RM.
Aldosterone-mediated regulation of Na+,K+-ATPase gene expression in adult and neonatal rat cardiocytes.
J Biol Chem
266:
12058-12066,
1991
170.
Ivic, M,
and
Klisic L.
A histochemical demonstration of the Na+ + K+-ATPase activity in the thyroid and the effect of cyclic adenosine monophosphate (c-AMP).
Experientia
34:
1513-1514,
1978[ISI][Medline].
171.
Jarmakani, JM,
Nagatomo T,
Nakazawa M,
and
Langer GA.
Effect of hypoxia on myocardial high-energy phosphates in the neonatal mammalian heart.
Am J Physiol Heart Circ Physiol
235:
H475-H481,
1978
172.
Johannsson, A,
Smith GA,
and
Metcalfe JC.
The effect of bilayer thickness on the activity of (Na+,K+)-ATPase.
Biochim Biophys Acta
641:
416-421,
1981[ISI][Medline].
173.
Jones, DH,
Davies TC,
and
Kidder GM.
Embryonic expression of the putative subunit of the sodium pump is required for acquisition of fluid transport capacity during mouse blastocyst development.
J Cell Biol
139:
1545-1552,
1997
174.
Jordan, C,
Puschel B,
Koob R,
and
Drenckhahn D.
Identification of a binding motif for ankyrin on the -subunit of Na+,K+-ATPase.
J Biol Chem
270:
29971-29975,
1995
175.
Kaibara, K,
Akasu T,
Tokimasa T,
and
Koketsu K.
-Adrenergic modulation of the Na+-K+ pump in frog skeletal muscles.
Pflügers Arch
405:
24-28,
1985[ISI][Medline].
176.
Kalant, H,
and
Rangaraj N.
Interaction of catecholamines and ethanol on the kinetics of rat brain (Na+ + K+)-ATPase.
Eur J Pharmacol
70:
157-166,
1981[ISI][Medline].
177.
Kansra, V,
Chen C,
and
Lokhandwala MF.
Dopamine causes stimulation of protein kinase C in rat renal proximal tubules by activating dopamine D1 receptors.
Eur J Pharmacol
289:
391-394,
1995[Medline].
178.
Kansra, V,
Chen CJ,
and
Lokhandwala MF.
Dopamine fails to stimulate protein kinase C activity in renal proximal tubules of spontaneously hypertensive rats.
Clin Exp Hypertens
17:
837-845,
1995[ISI][Medline].
179.
Kansra, V,
Hussain T,
and
Lokhandwala MF.
Alterations in dopamine DA1 receptor and G proteins in renal proximal tubules of old rats.
Am J Physiol Renal Physiol
273:
F53-F59,
1997
180.
Karli, JN,
Karikas GA,
Hatzipavlou PK,
Levis GM,
and
Moulopoulos SN.
The inhibition of Na+ and K+ stimulated ATPase activity of rabbit and dog heart sarcolemma by lysophosphatidyl choline.
Biochem Biophys Res Commun
24:
1869-1876,
1979.
181.
Karlish, SJ,
Goldshleger R,
and
Stein WD.
A 19-kDa C-terminal tryptic fragment of the chain of Na/K-ATPase is essential for occlusion and transport of cations.
Proc Natl Acad Sci USA
87:
4566-4570,
1990[Abstract].
182.
Kashgarian, M,
Morrow JS,
Foellmer HG,
Mann AS,
Cianci C,
and
Ardito T.
Na,K-ATPase co-distributes with ankyrin and spectrin in renal tubular epithelial cells.
Prog Clin Biol Res
268B:
245-250,
1988.
183.
Khan, NA,
Quemener V,
and
Moulinoux JP.
Phorbol esters augment polyamine transport by influencing Na+-K+ pump in murine leukemia cells.
Exp Cell Res
199:
378-382,
1992[ISI][Medline].
184.
Kim, I,
and
Yeoun DS.
Effect of prostaglandin F2 on Na+-K+-ATPase activity in luteal membranes.
Biol Reprod
29:
48-55,
1983[Abstract].
185.
Kim, JW,
Lee Y,
Lee IA,
Kang HB,
Choe YK,
and
Choe IS.
Cloning and expression of human cDNA encoding Na+,K+-ATPase -subunit.
Biochim Biophys Acta
1350:
133-135,
1997[ISI][Medline].
186.
Kimelberg, HK,
and
Mayhew E.
Increased ouabain-sensitive 86Rb+ uptake and sodium and potassium ion-activated adenosine triphosphatase activity in transformed cell lines.
J Biol Chem
250:
100-104,
1975[Abstract].
187.
Kimelberg, HK,
and
Papahadjopoulos D.
Phospholipid requirements for (Na+,K+)-ATPase activity: head group specificity and fatty acid fluidity.
Biochim Biophys Acta
282:
277-292,
1972[ISI][Medline].
188.
Kiroytcheva, M,
Cheval L,
Carranza ML,
Martin PY,
Favre H,
Doucet A,
and
Féraille E.
Effect of cAMP on the activity and the phosphorylation of Na,K-ATPase in rat thick ascending limb of Henle.
Kidney Int
55:
1819-1831,
1999[ISI][Medline].
189.
Komabayashi, T,
Izawa T,
Nakamura T,
Suda K,
Shinoda S,
and
Tsuboi M.
Effects of cyclic nucleotide derivatives on the Na+ pump activity and the release of sialic acid in dog submandibular glands.
Res Commun Mol Pathol Pharmacol
60:
137-140,
1988.
190.
Koob, R,
Kraemer D,
Trippe G,
Aebi U,
and
Drenckhahn D.
Association of kidney and parotid Na+, K+-ATPase microsomes with actin and analogs of spectrin and ankyrin.
Eur J Cell Biol
53:
93-100,
1990[ISI][Medline].
191.
Koop, A,
and
Cobbold PH.
Continuous bioluminescent monitoring of cytoplasmic ATP in single isolated rat hepatocytes during metabolic poisoning.
Biochem J
295:
165-170,
1993[ISI][Medline].
192.
Kowdley, GC,
Ackerman SJ,
Chen Z,
Szabo G,
Jones LR,
and
Moorman JR.
Anion, cation, and zwitterion selectivity of phospholemman channel molecules.
Biophys J
72:
141-145,
1997[Abstract].
193.
Kraemer, D,
Koob R,
Friedrichs B,
and
Drenckhahn D.
Two novel peripheral membrane proteins, pasin 1 and pasin 2, associated with Na+,K+-ATPase in various cells and tissues.
J Cell Biol
111:
2375-2383,
1990[Abstract].
194.
Küster B, Shainskaya A, Mann M, and Karlish SJD. Mass
spectrometric analysis of the subunit of Na,K-ATPase. In:
Proceedings of the 9th International Conference on the Na/K Pump
and Related Pumps. Amsterdam: Elsevier Science. In press.
195.
Küster, B,
Shainskaya A,
Pu HX,
Goldshleger R,
Blostein R,
Mann M,
and
Karlish SJD
A new variant of the subunit of renal Na,K-ATPase. Identification by mass spectrometry, antibody binding and expression in cultured cells.
J Biol Chem.
275:
19441-19446,
2000.
196.
Lahaye, P,
Tazi KA,
Rona JP,
Dellis O,
Lebrec D,
and
Moreau R.
Effects of protein kinase C modulators on Na+/K+ adenosine triphosphatase activity and phosphorylation in aortae from rats with cirrhosis.
Hepatology
28:
663-669,
1998[ISI][Medline].
197.
Laredo, J,
Hamilton BP,
and
Hamlyn JM.
Ouabain is secreted by bovine adrenocortical cells.
Endocrinology
135:
794-797,
1994[Abstract].
198.
Lattimer, SA,
Sima AAF,
and
Greene DA.
In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists.
Am J Physiol Endocrinol Metab
256:
E264-E269,
1989
199.
Lauf, PK,
Parmalee ML,
Snyder JJ,
and
Tosteson DC.
Enzymatic modification of the L and M antigens in LK and HK erythrocytes and their membranes. The action of neuraminidase and trypsin.
J Membr Biol
4:
52-67,
1971[ISI].
200.
Lavoie, L,
Roy D,
Ramlal T,
Dombrowski L,
Martin-Vasallo P,
Marette A,
Carpentier JL,
and
Klip A.
Insulin-induced translocation of Na+-K+-ATPase subunits to the plasma membrane is muscle fiber type specific.
Am J Physiol Cell Physiol
270:
C1421-C1429,
1996
201.
Lea, JP,
Sands JM,
McMahon SJ,
and
Tumlin JA.
Evidence that the inhibition of Na+/K+-ATPase activity by FK506 involves calcineurin.
Kidney Int
46:
647-652,
1994[ISI][Medline].
202.
Lear, S,
Cohen BJ,
Silva P,
Lechene C,
and
Epstein FH.
cAMP activates the sodium pump in cultured cells of the elasmobranch rectal gland.
J Am Soc Nephrol
2:
1523-1528,
1992[Abstract].
203.
Lee, MR.
Dopamine and the kidney.
Clin Sci (Colch)
62:
439-448,
1982[ISI][Medline].
204.
Li, D,
Cheng SXJ,
Fisone G,
Caplan MJ,
Ohtomo Y,
and
Aperia A.
Effects of okadaic acid, calyculin A, and PDBu on state of phosphorylation of rat renal Na+-K+-ATPase.
Am J Physiol Renal Physiol
275:
F863-F869,
1998
205.
Li, D,
Sweeney G,
Wang Q,
and
Klip A.
Participation of PI3K and atypical PKC in Na+-K+-ATPase stimulation by IGF-I in VSMC.
Am J Physiol Heart Circ Physiol
276:
H2109-H2116,
1999
206.
Li, KX,
and
Sperelakis N.
Isoproterenol- and insulin-induced hyperpolarization in rat skeletal muscle.
J Cell Physiol
157:
631-636,
1993[ISI][Medline].
207.
Lifton, RP.
Molecular genetics of human blood pressure variation.
Science
15:
2381-2387,
1996.
208.
Lindinger, MI,
and
Sjogaard G.
Potassium regulation during exercise and recovery.
Sports Med
11:
382-401,
1991[ISI][Medline].
209.
Lingham, RB,
and
Sen AK.
Regulation of rat brain (Na+ +K+)-ATPase activity by cyclic AMP.
Biochim Biophys Acta
688:
475-485,
1982[ISI][Medline].
210.
Lipton, P,
and
Whittingham TS.
Reduced ATP concentration as a basis for synaptic transmission failure during hypoxia in the in vitro guinea-pig hippocampus.
J Physiol (Lond)
325:
51-65,
1982[ISI][Medline].
211.
Liu, WS,
and
Heckman CA.
The sevenfold way of PKC regulation.
Cell Signal
10:
529-542,
1998[ISI][Medline].
212.
Logvinenko, NS,
Dulubova I,
Fedosova N,
Larsson SH,
Nairn AC,
Esmann M,
Greengard P,
and
Aperia A.
Phosphorylation by protein kinase C of serine-23 of the 1 subunit of rat Na+,K+-ATPase affects its conformational equilibrium.
Proc Natl Acad Sci USA
93:
9132-9137,
1996
213.
Lowndes, JM,
Hokin-Neaverson M,
and
Bertics PJ.
Kinetics of phosphorylation of Na+/K+-ATPase by protein kinase C.
Biochim Biophys Acta
1052:
143-151,
1990[ISI][Medline].
214.
Lowndes, JM,
Hokin-Neaverson M,
and
Ruoho AE.
Photoaffinity labeling of (Na++K+)-ATPase with [125I]iodoazidocymarin.
J Biol Chem
259:
10533-10538,
1984
215.
Luly, P,
Baldini P,
Cocco C,
Incerpi S,
and
Tria E.
Effect of chlorpropamide and phenformin on rat liver: the effect on plasma membrane-bound enzymes and cyclic AMP content of hepatocytes in vitro.
Eur J Pharmacol
46:
153-164,
1977[ISI][Medline].
216.
Lynch, CJ,
Mader AC,
McCall KM,
Ng YC,
and
Hazen SA.
Okadaic acid stimulates ouabain-sensitive 86Rb+-uptake and phosphorylation of the Na+/K+-ATPase -subunit in rat hepatocytes.
FEBS Lett
355:
157-162,
1994[ISI][Medline].
217.
Lynch, CJ,
Wilson PB,
Blackmore PF,
and
Exton JH.
The hormone-sensitive hepatic Na+-pump. Evidence for regulation by diacylglycerol and tumor promoters.
J Biol Chem
261:
14551-14556,
1986
218.
MacDonald, JA,
and
Storey KB.
Regulation of ground squirrel Na+K+-ATPase activity by reversible phosphorylation during hibernation.
Biochem Biophys Res Commun
254:
424-429,
1999[ISI][Medline].
219.
Manunta, P,
Cerutti R,
Bernardi L,
Stella P,
and
Bianchi G.
Renal genetic mechanisms of essential hypertension.
J. Nephrol.
10:
172-178,
1997[ISI][Medline].
220.
Marcaida, G,
Kosenko E,
Minana MD,
Grisolia S,
and
Felipo V.
Glutamate induces a calcineurin-mediated dephosphorylation of Na+,K+-ATPase that results in its activation in cerebellar neurons in culture.
J Neurochem
66:
99-104,
1996[ISI][Medline].
221.
Marcus, MM,
Apell H-J,
Roudna M,
Schwendener RA,
Weder H-G,
and
Läuger P.
(Na+,K+)-ATPase in artificial lipid vesicles: influence of lipid structure on pumping rate.
Biochim Biophys Acta
854:
270-278,
1986[ISI][Medline].
222.
Marette, A,
Krischer J,
Lavoie L,
Ackerley C,
Carpentier JL,
and
Klip A.
Insulin increases the Na+-K+-ATPase -subunit in the surface of rat skeletal muscle: morphological evidence.
Am J Physiol Cell Physiol
265:
C1716-C1722,
1993
223.
Martinez, JR,
Cassity N,
and
Barker S.
Differential effects of prostaglandins and isoproterenol on cAMP content and Na,K pump activity in rat submandibular acini.
Experientia
43:
1013-1015,
1987[ISI][Medline].
224.
Marver, D,
Lear S,
Marver LT,
Silva P,
and
Epstein FH.
Cyclic AMP-dependent stimulation of Na,K-ATPase in shark rectal gland.
J Membr Biol
94:
205-215,
1986[ISI][Medline].
225.
McKee, M,
Scavone C,
and
Nathanson JA.
Nitric oxide, cGMP, and hormone regulation of active sodium transport.
Proc Natl Acad Sci USA
91:
12056-12060,
1994
226.
Meister, B,
and
Aperia A.
Molecular mechanisms involved in catecholamine regulation of sodium transport.
Semin Nephrol
13:
41-49,
1993[ISI][Medline].
227.
Meister, B,
Fryckstedt J,
Schalling M,
Cortés R,
Hökfelt T,
Aperia A,
Hemmings HCJ,
Nairn AC,
Ehrlich M,
and
Greengard P.
Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.
Proc Natl Acad Sci USA
86:
8068-8072,
1989[Abstract].
228.
Mercer, RW,
Biemesderfer D,
Bliss DP, Jr,
Collins JH,
and
Forbush B, III.
Molecular cloning and immunological characterization of the polypeptide, a small protein associated with the Na,K-ATPase.
J Cell Biol
121:
579-586,
1993[Abstract].
229.
Middleton, JP,
Khan WA,
Collinsworth G,
Hannun YA,
and
Medford RM.
Heterogeneity of protein kinase C-mediated rapid regulation of Na/K-ATPase in kidney epithelial cells.
J Biol Chem
268:
15958-15964,
1993
230.
Milusheva, EA,
Doda M,
Baranyi M,
and
Vizi ES.
Effect of hypoxia and glucose deprivation on ATP level, adenylate energy charge and [Ca2+]o-dependent and independent release of [3H]dopamine in rat striatal slices.
Neurochem Int
28:
501-507,
1996[ISI][Medline].
231.
Minor, NT,
Sha Q,
Nichols CG,
and
Mercer RW.
The subunit of the Na,K-ATPase induces cation channel activity.
Proc Natl Acad Sci USA
95:
6521-6525,
1998
232.
Mito, T,
and
Delamere NA.
Alteration of active Na-K transport on protein kinase C activation in cultured ciliary epithelium.
Invest Ophthalmol Vis Sci
34:
539-546,
1993[Abstract].
233.
Molitoris, BA,
Geerdes A,
and
McIntosh JR.
Dissociation and redistribution of Na+,K+-ATPase from its surface membrane actin cytoskeletal complex during cellular ATP depletion.
J Clin Invest
88:
462-469,
1991[ISI][Medline].
234.
Moore, ED,
and
Fay FS.
Isoproterenol stimulates rapid extrusion of sodium from isolated smooth muscle cells.
Proc Natl Acad Sci USA
90:
8058-8062,
1993
235.
Moorman, JR,
Ackerman SJ,
Kowdley GC,
Griffin MP,
Mounsey JP,
Chen Z,
Cala SE,
O'Brian JJ,
Szabo G,
and
Jones LR.
Unitary anion currents through phospholemman channel molecules.
Nature
377:
737-740,
1995[ISI][Medline].
236.
Moorman, JR,
Palmer CJ,
John JE, III,
Durieux ME,
and
Jones LR.
Phospholemman expression induces a hyperpolarization-activated chloride current in Xenopus oocytes.
J Biol Chem
267:
14551-14554,
1992
237.
Morrison, BW,
and
Leder P.
neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
Oncogene
9:
3417-3426,
1994[ISI][Medline].
238.
Morrison, BW,
Moorman JR,
Kowdley GC,
Kobayashi YM,
Jones LR,
and
Leder P.
Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytes.
J Biol Chem
270:
2176-2182,
1995
239.
Mrsny, RJ,
and
Meizel S.
Initial evidence for the modification of hamster sperm Na+, K+-ATPase activity by cyclic nucleotide-mediated processes.
Biochem Biophys Res Commun
112:
132-138,
1983[ISI][Medline].
240.
Munzer, JS,
Daly SE,
Jewell-Motz EA,
Lingrel JB,
and
Blostein R.
Tissue- and isoform-specific kinetic behaviour of the Na,K-ATPase.
J Biol Chem
269:
16668-16676,
1994
241.
Munzer, JS,
Silvius JR,
and
Blostein R.
Delivery of ion pumps from exogenous membrane-rich sources in mammalian red blood cells.
J Biol Chem
267:
5205-5210,
1992.
242.
Muto, S,
Nemoto J,
Ohtaka A,
Watanabe Y,
Yamaki M,
Kawakami K,
Nagano K,
and
Asano Y.
Differential regulation of Na+-K+-ATPase gene expression by corticosteroids in vascular smooth muscle cells.
Am J Physiol Cell Physiol
270:
C731-C739,
1996
243.
Nakano, T,
Fujimoto K,
Honda Y,
and
Ogawa K.
Cytochemistry of protein kinase C and Na-K-ATPase in rabbit ciliary processes treated with phorbol ester.
Invest Ophthalmol Vis Sci
33:
3455-3462,
1992[Abstract].
244.
Nathanson, JA,
Scavone C,
Scanlon C,
and
McKee M.
The cellular Na+ pump as a site of action for carbon monoxide and glutamate: a mechanism for long-term modulation of cellular activity.
Neuron
14:
781-794,
1995[ISI][Medline].
245.
Nelson, WJ,
and
Veshnock PJ.
Ankyrin binding to (Na+ + K+) ATPase and implications for the organization of membrane domains in polarized cells.
Nature
328:
533-536,
1987[ISI][Medline].
246.
Nemoto, J,
Muto S,
Ohtaka A,
Kawakami K,
and
Asano Y.
Serum transcriptionally regulates Na+-K+-ATPase gene expression in vascular smooth muscle cells.
Am J Physiol Cell Physiol
273:
C1088-C1099,
1997
247.
Nestor, NB,
Lane LK,
and
Blostein R.
Effects of protein kinase modulators on the sodium pump activities of HeLa cells transfected with distinct isoforms of Na,K-ATPase.
Ann NY Acad Sci
834:
579-581,
1997[ISI][Medline].
248.
Nishi, A,
Bertorello AM,
and
Aperia A.
High salt diet down-regulates proximal tubule Na+,K+-ATPase activity in Dahl salt-resistant but not in Dahl salt-sensitive rats: evidence of defective dopamine regulation.
Acta Physiol Scand
144:
263-267,
1992[ISI][Medline].
249.
Nishi, A,
Eklof AC,
Bertorello AM,
and
Aperia A.
Dopamine regulation of renal Na+,K+-ATPase activity is lacking in Dahl salt-sensitive rats.
Hypertension
21:
767-771,
1993[Abstract].
250.
Nowicki, S,
Chen SL,
Aizman O,
Cheng XJ,
Li D,
Nowicki C,
Nairn A,
Greengard P,
and
Aperia A.
20-Hydroxyeicosa-tetraenoic acid (20-HETE) activates protein kinase C. Role in regulation of rat renal Na+,K+-ATPase.
J Clin Invest
99:
1224-1230,
1997
251.
O'Donnell, ME,
Bush EN,
Holleman W,
and
Owen NE.
Biologically active atrial natriuretic peptides selectively activate Na/K/Cl cotransport in vascular smooth muscle cells.
J Pharmacol Exp Ther
243:
822-828,
1987[Abstract].
252.
Oguchi, A,
Ikeda U,
Kanbe T,
Tsuruya Y,
Yamamoto K,
Kawakami K,
Medford RM,
and
Shimada K.
Regulation of Na-K-ATPase gene expression by aldosterone in vascular smooth muscle cells.
Am J Physiol Heart Circ Physiol
265:
H1167-H1172,
1993
253.
Ohtomo, Y,
Aperia A,
Sahlgren B,
Johansson BL,
and
Wahren J.
C-peptide stimulates rat renal tubular Na+,K+-ATPase activity in synergism with neuropeptide Y.
Diabetologia
39:
199-205,
1996[ISI][Medline].
254.
Oishi, K,
Zheng B,
and
Kuo JF.
Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine and oleic acid.
J Biol Chem
265:
70-75,
1990
255.
Oishi, K,
Zheng B,
White JF,
Vogler WR,
and
Kuo JF.
Inhibition of Na,K-ATPase and sodium pump by anticancer ether lipids and protein kinase C inhibitors ET-18-OCH3 and BM 41.440.
Biochem Biophys Res Commun
157:
1000-1006,
1988[ISI][Medline].
256.
Omatsu-Kanbe, M,
and
Kitasato H.
Insulin stimulates the translocation of Na+/K+-dependent ATPase molecules from intracellular stores to the plasma membrane in frog skeletal muscle.
Biochem J
272:
727-733,
1990[ISI][Medline].
257.
Ominato, M,
Satoh T,
and
Katz AI.
Regulation of Na-K-ATPase activity in the proximal tubule: role of the protein kinase C pathway and of eicosanoids.
J Membr Biol
152:
235-243,
1996[ISI][Medline].
258.
O'Neil, RG.
Aldosterone regulation of sodium and potassium transport in the cortical collecting duct.
Semin Nephrol
10:
365-374,
1990[ISI][Medline].
259.
Or, E,
Goldshleger ED,
Tal DM,
and
Karlish SJ.
Solubilization of a complex of tryptic fragments of Na,K-ATPase containing occluded Rb ions and bound ouabain.
Biochemistry
35:
6853-6864,
1996[ISI][Medline].
260.
Ostenson, CG,
Agren A,
Brolin SE,
and
Petersson B.
Adenine nucleotide concentrations in A2-cell rich and normal pancreatic islets of the guinea pig.
Diabetes Metab
6:
5-11,
1980[ISI].
261.
Owada, S,
Larsson O,
Arkhammar P,
Katz AI,
Chibalin AV,
Berggren PO,
and
Bertorello AM.
Glucose decreases Na+,K+-ATPase activity in pancreatic -cells. An effect mediated via Ca2+-independent phospholipase A2 and protein kinase C-dependent phosphorylation of the
-subunit.
J Biol Chem
274:
2000-2008,
1999
262.
Paller, MS.
Lateral mobility of Na,K-ATPase and membrane lipids in renal cells. Importance of cytoskeletal integrity.
J Membr Biol
142:
127-135,
1994[ISI][Medline].
263.
Palmer, CJ,
Scott BT,
and
Jones LR.
Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium.
J Biol Chem
266:
11126-11130,
1991
264.
Palmer, LG,
Antonian L,
and
Frindt G.
Regulation of the Na-K pump of the rat cortical collecting tubule by aldosterone.
J Gen Physiol
102:
43-57,
1993[Abstract].
265.
Paris, S,
and
Rozengurt E.
Cyclic AMP stimulation of Na-K pump activity in quiescent Swiss 3T3 cells.
J Cell Physiol
112:
273-280,
1982[ISI][Medline].
266.
Parkington, HC,
Tonta MA,
Davies NK,
Brennecke SP,
and
Coleman HA.
Hyperpolarization and slowing of the rate of contraction in human uterus in pregnancy by prostaglandins E2 and F2: involvement of the Na+ pump.
J Physiol (Lond)
514:
229-243,
1999
267.
Pedemonte, CH,
Pressley TA,
Lokhandwala MF,
and
Cinelli AR.
Regulation of Na,K-ATPase transport activity by protein kinase C.
J Membr Biol
155:
219-227,
1997[ISI][Medline].
268.
Pellanda, AM,
Gaeggeler HP,
Horisberger JD,
and
Rossier BC.
Sodium-independent effect of aldosterone on initial rate of ouabain binding in A6 cells.
Am J Physiol Cell Physiol
262:
C899-C906,
1992
269.
Petty, KJ,
Kokko JP,
and
Marver D.
Secondary effect of aldosterone on Na-K-ATPase activity in the rabbit cortical collecting tubule.
J Clin Invest
68:
1514-1521,
1981[ISI][Medline].
270.
Pfeiffer, R,
Beron J,
and
Verrey F.
Regulation of Na+ pump function by aldosterone is -subunit isoform specific.
J Physiol (Lond)
516:
647-655,
1999
271.
Pinto-do-O, PC,
Chibalin AV,
Katz AI,
Soares-da-Silva P,
and
Bertorello AM.
Short-term vs sustained inhibition of proximal tubule Na,K-ATPase activity by dopamine: cellular mechanisms.
Clin Exp Hypertens
19:
73-86,
1997[ISI][Medline].
272.
Pitovski, DZ,
Drescher MJ,
Kerr TP,
and
Drescher DG.
Aldosterone mediates an increase in [3H]ouabain binding at Na+, K+-ATPase sites in the mammalian inner ear.
Brain Res
601:
273-278,
1993[ISI][Medline].
273.
Pontiggia, L,
Winterhalter K,
and
Gloor SM.
Inhibition of Na,K-ATPase activity by cGMP is isoform-specific in brain endothelial cells.
FEBS Lett
436:
466-470,
1998[ISI][Medline].
274.
Postnov, YV,
Kravtsov GM,
Orlov SN,
Pokudin NI,
Postnov IY,
and
Kotelevtsev YV.
Effect of protein kinase C activation on cytoskeleton and cation transport in human erythrocytes. Reproduction of some membrane abnormalities revealed in essential hypertension.
Hypertension
12:
267-273,
1988[Abstract].
275.
Ragolia, L,
Cherpalis B,
Srinivasan M,
and
Begum N.
Role of serine/threonine protein phosphatases in insulin regulation of Na+/K+-ATPase activity in cultured rat skeletal muscle cells.
J Biol Chem
272:
23653-23658,
1997
276.
Ramirez-Gil, JF,
Trouve P,
Mougenot N,
Carayon A,
Lechat P,
and
Charlemagne D.
Modifications of myocardial Na+,K+-ATPase isoforms and Na+/Ca2+ exchanger in aldosterone/salt-induced hypertension in guinea pigs.
Cardiovasc Res
38:
451-462,
1998[ISI][Medline].
277.
Rangaraj, N,
Kalant H,
and
Beauge F.
-Adrenergic receptor involvement in norepinephrine-ethanol inhibition of rat brain Na+-K+ ATPase and in ethanol tolerance.
Can J Physiol Pharmacol
63:
1075-1079,
1985[ISI][Medline].
278.
Rashed, SM,
and
Songu-Mize E.
Regulation of Na+,K+-ATPase activity by dopamine in cultured rat aortic smooth muscle cells.
Eur J Pharmacol
305:
223-230,
1996[ISI][Medline].
279.
Rashed, SM,
and
Songu-Mize E.
Regulation of Na+-pump activity by dopamine in rat tail arteries.
Eur J Pharmacol
284:
289-297,
1995[ISI][Medline].
280.
Rayson, BM,
and
Gupta RK.
Steroids, intracellular sodium levels, and Na+/K+-ATPase regulation.
J Biol Chem
260:
12740-12743,
1985
281.
Reeves, AS,
Collins JH,
and
Schwartz A.
Isolation and characterization of (Na,K)-ATPase proteolipid.
Biochem Biophys Res Commun
95:
1591-1598,
1980[ISI][Medline].
282.
Rivas, E,
Lew V,
and
De Robertis E.
(3H)ouabain binding to a hydrophobic protein from electroplax membranes.
Biochim Biophys Acta
290:
419-423,
1972[ISI][Medline].
283.
Rodriguez De Lores Arnaiz, G,
and
Mistrorigo De Pacheco M.
Regulation of (Na+, K+) adenosinetriphosphatase of nerve ending membranes: action of norepinephrine and a soluble factor.
Neurochem Res
3:
733-744,
1978[ISI][Medline].
284.
Rogers, TB,
and
Lazdunski M.
Photoaffinity labelling of a small protein component of a purified (Na+-K+) ATPase.
FEBS Lett
98:
373-376,
1979[ISI][Medline].
285.
Rokaw, MD,
West ME,
Palevsky PM,
and
Johnson JP.
FK-506 and rapamycin but not cyclosporin inhibit aldosterone-stimulated sodium transport in A6 cells.
Am J Physiol Cell Physiol
271:
C194-C202,
1996
286.
Rossi, B,
Vuilleumier P,
Gache C,
Balerna M,
and
Lazdunski M.
Affinity labeling of the digitalis receptor with p-nitrophenyltriazene-ouabain, a highly specific alkylating agent.
J Biol Chem
255:
9936-9941,
1980
287.
Rossi, G,
Manunta P,
Hamlyn JM,
Pavan E,
DeToni R,
Semplicini A,
and
Pessina AC.
Endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
J Hypertens
13:
1181-1191,
1995[ISI][Medline].
288.
Sampson, SR,
Brodie C,
and
Alboim SV.
Role of protein kinase C in insulin activation of the Na-K pump in cultured skeletal muscle.
Am J Physiol Cell Physiol
266:
C751-C758,
1994
289.
Sargeant, RJ,
Liu Z,
and
Klip A.
Action of insulin on Na+-K+-ATPase and the Na+-K+-2Cl cotransporter in 3T3-L1 adipocytes.
Am J Physiol Cell Physiol
269:
C217-C225,
1995
290.
Sasaguri, T,
and
Watson SP.
Phorbol esters inhibit smooth muscle contractions through activation of Na+-K+-ATPase.
Br J Pharmacol
99:
237-242,
1990[Abstract].
291.
Satoh, T,
Cohen HT,
and
Katz AI.
Different mechanisms of renal Na-K-ATPase regulation by protein kinases in proximal and distal nephron.
Am J Physiol Renal Fluid Electrolyte Physiol
265:
F399-F405,
1993
292.
Satoh, T,
Cohen HT,
and
Katz AI.
Intracellular signaling in the regulation of renal Na-K-ATPase. I. Role of cyclic AMP and phospholipase A2.
J Clin Invest
89:
1496-1500,
1992[ISI][Medline].
293.
Satoh, T,
Cohen HT,
and
Katz AI.
Intracellular signaling in the regulation of renal Na-K-ATPase. II. Role of eicosanoids.
J Clin Invest
91:
409-415,
1993[ISI][Medline].
294.
Satoh, T,
Ominato M,
and
Katz AI.
Different mechanisms of renal Na-K-ATPase regulation by dopamine in the proximal and distal nephron.
Hypertens Res
18:
S137-S140,
1995[Medline].
295.
Scavone, C,
Scanlon C,
McKee M,
and
Nathanson JA.
Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase.
J Pharmacol Exp Ther
272:
1036-1043,
1995[Abstract].
296.
Scheiner-Bobis, G,
and
Farley RA.
Subunit requirements for expression of functional sodium pumps in yeast cells.
Biochim Biophys Acta
1193:
226-234,
1994[ISI][Medline].
297.
Schneider, R,
Wray V,
Nimtz M,
Lehmann WD,
Kirch U,
Antolovic R,
and
Schoner W.
Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump.
J Biol Chem
273:
784-792,
1998
298.
Schramm, CM,
and
Grunstein MM.
Mechanisms of protein kinase C regulation of airway contractility.
J Appl Physiol
66:
1935-1941,
1989
299.
Schreiner, J,
Nell G,
and
Loeschke K.
Effect of diphenolic laxatives on Na+-K+-activated ATPase and cyclic nucleotide content of rat colon mucosa in vivo.
Naunyn Schmiedebergs Arch Pharmacol
313:
249-255,
1980[ISI][Medline].
300.
Shahedi, M,
Laborde K,
Azimi S,
Hamdani S,
and
Sachs C.
Mechanisms of dopamine effects on Na-K-ATPase activity in Madin-Darby canine kidney (MDCK) epithelial cells.
Pflügers Arch
429:
832-840,
1995[ISI][Medline].
301.
Shahedi, M,
Laborde K,
Bussieres L,
Dechaux M,
and
Sachs C.
Protein kinase C activation causes inhibition of Na/K-ATPase activity in Madin-Darby canine kidney epithelial (MDCK) cells.
Pflügers Arch
420:
269-274,
1992[ISI][Medline].
302.
Shahedi, M,
Laborde K,
Bussieres L,
and
Sachs C.
Acute and early effects of aldosterone on Na-K-ATPase activity in Madin-Darby canine kidney epithelial cells.
Am J Physiol Renal Fluid Electrolyte Physiol
264:
F1021-F1026,
1993
303.
Sharon, P,
Karmeli F,
and
Rachmilewitz D.
PGE2 mediates the effect of pentagastrin on intestinal adenylate cyclase and Na-K-ATPase activities.
Prostaglandins
21:
81-87,
1981[Medline].
304.
Shimbo, K,
Brassard DL,
Lamb RA,
and
Pinto LH.
Viral and cellular small integral membrane proteins can modify ion channels endogenous to Xenopus oocytes.
Biophys J
69:
1819-1829,
1995[Abstract].
305.
Shindo, H,
Tawata M,
and
Onaya T.
Cyclic adenosine 3',5'-monophosphate enhances sodium, potassium-adenosine triphosphatase activity in the sciatic nerve of streptozotocin-induced diabetic rats.
Endocrinology
132:
510-516,
1993[Abstract].
306.
Shulman, LM,
and
Fox DA.
Dopamine inhibits mammalian photoreceptor Na+,K+-ATPase activity via a selective effect on the isozyme.
Proc Natl Acad Sci USA
93:
8034-8039,
1996
307.
Skou, JC.
The influence of some cations on an adenosine triphosphatase from peripheral nerve.
Biochim Biophys Acta
23:
394-401,
1957[ISI].
308.
Slobodyansky, E,
Aoki Y,
Gaznabi AK,
Aviles DH,
Fildes RD,
and
Jose PA.
Dopamine and protein phosphatase activity in renal proximal tubules.
Am J Physiol Renal Fluid Electrolyte Physiol
268:
F279-F284,
1995
309.
Soltoff, SP,
and
Mandel LJ.
Active ion transport in the renal proximal tubule. II. Ionic dependance of the Na pump.
J Gen Physiol
84:
623-642,
1984[Abstract].
310.
Soltoff, SP,
and
Mandel LJ.
Active ion transport in the renal proximal tubule. III. The ATP dependance of the Na pump.
J Gen Physiol
84:
643-662,
1984[Abstract].
311.
Stewart, DJ,
and
Sen AK.
Role of cyclic GMP in cholinergic activation of Na-K pump in duck salt gland.
Am J Physiol Cell Physiol
240:
C207-C214,
1981[Abstract].
312.
Stewart, WC,
Pekala PH,
and
Lieberman EM.
Acute and chronic regulation of Na+/K+-ATPase transport activity in the RN22 Schwann cell line in response to stimulation of cyclic AMP production.
Glia
23:
349-360,
1998[ISI][Medline].
313.
Svoboda, P,
Teisinger J,
and
Vyskocil F.
Effect of catecholamines and metal chelating agents on the brain and brown adipose tissue Na,K-ATPase.
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol
84:
283-290,
1986[ISI].
314.
Swann, AC.
Stimulation of brain Na+,K+-ATPase by norepinephrine in vivo: prevention by receptor antagonists and enhancement by repeated stimulation.
Brain Res
260:
338-341,
1983[ISI][Medline].
315.
Sweadner KJ, Arystarkhova E, Wetzel RK, and Rael E. Splice
variants of the Na,K-ATPase gamma subunit. In: Proceedings of the
9th International Conference on the Na/K Pump and Related Pumps.
Amsterdam: Elsevier Science. In press.
316.
Sweeney, G,
and
Klip A.
Regulation of the Na+/K+-ATPase by insulin: why and how?
Mol Cell Biochem
182:
121-133,
1998[ISI][Medline].
317.
Sweeney, G,
Somwar R,
Ramlal T,
Martin-Vasallo P,
and
Klip A.
Insulin stimulation of K+ uptake in 3T3-L1 fibroblasts involves phosphatidylinositol 3-kinase and protein kinase C-.
Diabetologia
41:
1199-1204,
1998[ISI][Medline].
318.
Sykova, E.
Extracellular K+ accumulation in the central nervous system.
Prog Biophys Mol Biol
42:
135-189,
1983[ISI][Medline].
319.
Syrén, ML.
Effect of atrial natriuretic factor and fate of cyclic-guanosine-monophosphate in the rat kidney.
Acta Physiol Scand
160:
1-7,
1997[ISI][Medline].
320.
Szekeres, L.
On the mechanism and possible therapeutic application of delayed cardiac adaptation to stress.
Can J Cardiol
12:
177-185,
1996[ISI][Medline].
321.
Takemoto, F,
Cohen H,
Satoh T,
and
Katz A.
Dopamine inhibits Na/K-ATPase in single tubules and cultured cells from distal nephron.
Pflügers Arch
421:
302-306,
1992[ISI][Medline].
322.
Tamaoki, J,
Tagaya E,
Yamawaki I,
and
Konno K.
Hypoxia impairs nitrovasodilator-induced pulmonary vasodilation: role of Na-K-ATPase activity.
Am J Physiol Lung Cell Mol Physiol
271:
L172-L177,
1996
323.
Taub, ML,
Wang Y,
Yang IS,
Fiorella P,
and
Lee SM.
Regulation of the Na,K-ATPase activity of Madin-Darby canine kidney cells in defined medium by prostaglandin E1 and 8-bromocyclic AMP.
J Cell Physiol
151:
337-346,
1992[ISI][Medline].
324.
Therien, AG,
and
Blostein R.
K+/Na+ antagonism at cytoplasmic cation activation sites of Na+-K+-ATPase: a tissue-specific mechanism of sodium pump regulation.
Am J Physiol Cell Physiol
277:
C891-C898,
1999
325.
Therien, AG,
Goldshleger R,
Karlish SJD,
and
Blostein R.
Tissue-specific distribution and modulatory role of the subunit of the Na,K-ATPase.
J Biol Chem
272:
32628-32634,
1997
326.
Therien, AG,
Karlish SJD,
and
Blostein R.
Expression and functional role of the subunit of the Na,K-ATPase in mammalian cells.
J Biol Chem
274:
12252-12256,
1999
327.
Therien, AG,
Nestor NB,
Ball WJ,
and
Blostein R.
Tissue-specific versus isoform-specific differences in cation-activation kinetics of the Na,K-ATPase.
J Biol Chem
271:
7104-7112,
1996
328.
Therien AG, Pu HX, Karlish SJD, and Blostein R. Structure/function
studies of the gamma subunit of renal Na,K-ATPase. In:
Proceedings of the 9th International Conference on the Na/K Pump
and Related Pumps. Amsterdam: Elsevier Science. In press.
329.
Thomas, R,
Gray P,
and
Andrews J.
Digitalis: its mode of action, receptor, and structure-activity relationships.
Adv Drug Res
19:
311-362,
1990.
330.
Tripodi, G,
Valtorta F,
Torielli L,
Chieregatti E,
Salardi S,
Trusolino L,
Menegon A,
Ferrari P,
Marchisio PC,
and
Bianchi G.
Hypertension-associated point mutations in the adducin and
subunits affect actin cytoskeleton and ion transport.
J Clin Invest
97:
2815-2822,
1996
331.
Tumlin, JA.
Expression and function of calcineurin in the mammalian nephron: physiological roles, receptor signaling, and ion transport.
Am J Kidney Dis
30:
884-895,
1997[ISI][Medline].
332.
Tung, P,
Pai G,
Johnson DG,
Punzalan R,
and
Levin SR.
Relationships between adenylate cyclase and Na+,K+-ATPase in rat pancreatic islets.
J Biol Chem
265:
3936-3939,
1990
333.
Tymiak, AA,
Norman JA,
Bolgar M,
DiDonato GC,
Lee H,
Parker WL,
Lo L-C,
Berova N,
Nakanishi K,
Haber E,
and
Haupert GT, Jr.
Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus.
Proc Natl Acad Sci USA
90:
8189-8193,
1993
334.
Vaandrager, AB,
and
de Jonge HR.
Signalling by cGMP-dependent protein kinases.
Mol Cell Biochem
157:
23-30,
1996[ISI][Medline].
335.
Vasilets, LA,
Fotis H,
and
Gartner EM.
Regulatory phosphorylation of the Na+/K+-ATPase from mammalian kidneys and Xenopus oocytes by protein kinases. Characterization of the phosphorylation site for PKC.
Ann NY Acad Sci
834:
585-587,
1997[ISI][Medline].
336.
Vasilets, LA,
Schmalzing G,
Madefessel K,
Haase W,
and
Schwarz W.
Activation of protein kinase C by phorbol ester induces downregulation of the Na+/K+-ATPase in oocytes of Xenopus laevis.
J Membr Biol
118:
131-142,
1990[ISI][Medline].
337.
Vermue, NA,
and
Den Hertog A.
The action of prostaglandins on ureter smooth muscle of guinea-pig.
Eur J Pharmacol
142:
163-167,
1987[ISI][Medline].
338.
Verrey, F,
Beron J,
and
Spindler B.
Corticosteroid regulation of renal Na,K-ATPase.
Miner Electrolyte Metab
22:
279-292,
1996[ISI][Medline].
339.
Verrey, F,
Schaerer E,
Zoerkler P,
Paccolat MP,
Geering K,
Kraehenbuhl JP,
and
Rossier BC.
Regulation by aldosterone of Na+,K+-ATPase mRNAs, protein synthesis, and sodium transport in cultured kidney cells.
J Cell Biol
104:
1231-1237,
1987[Abstract].
340.
Vieira-Coelho, MA,
Teixeira VA,
Finkel Y,
Soares-da-Silva P,
and
Bertorello AM.
Dopamine-dependent inhibition of jejunal Na+-K+-ATPase during high-salt diet in young but not in adult rats.
Am J Physiol Gastrointest Liver Physiol
275:
G1317-G1323,
1998
341.
Wald, H,
Popovtzer MM,
and
Garty H.
Differential regulation of CHIF mRNA by potassium intake and aldosterone.
Am J Physiol Renal Physiol
272:
F617-F623,
1997
342.
Wang, Y,
Gao J,
Mathias RT,
Cohen IS,
Sun X,
and
Baldo GJ.
-Adrenergic effects on Na+-K+ pump current in guinea-pig ventricular myocytes.
J Physiol (Lond)
509:
117-128,
1998
343.
Wang, ZM,
Yasui M,
and
Celsi G.
Differential effects of glucocorticoids and mineralocorticoids on the mRNA expression of colon ion transporters in infant rats.
Pediatr Res
38:
164-168,
1995[Abstract].
344.
Webb, RC,
and
Bohr DF.
Relaxation of vascular smooth muscle by isoproterenol, dibutyryl-cyclic AMP and theophylline.
J Pharmacol Exp Ther
217:
26-35,
1981[Abstract].
345.
Wehling, M,
Eisen C,
and
Christ M.
Aldosterone-specific membrane receptors and rapid non-genomic actions of mineralocorticoids.
Mol Cell Endocrinol
90:
C5-C9,
1992[ISI][Medline].
346.
Welling, PA,
Caplan M,
Sutters M,
and
Giebisch G.
Aldosterone-mediated Na/K-ATPase expression is isoform specific in the renal cortical collecting duct.
J Biol Chem
268:
23469-23476,
1993
347.
Whorwood, CB,
Ricketts ML,
and
Stewart PM.
Regulation of sodium-potassium adenosine triphosphate subunit gene expression by corticosteroids and 11 -hydroxysteroid dehydrogenase activity.
Endocrinology
135:
901-910,
1994[Abstract].
348.
Whorwood, CB,
and
Stewart PM.
Transcriptional regulation of Na/K-ATPase by corticosteroids, glycyrrhetinic acid and second messenger pathways in rat kidney epithelial cells.
J Mol Endocrinol
15:
93-103,
1995[Abstract].
349.
Wiener, H,
Nielsen JM,
Klaerke DA,
and
Jørgensen PL.
Aldosterone and thyroid hormone modulation of -,
-mRNA, and Na,K-pump sites in rabbit distal colon epithelium. Evidence for a novel mechanism of escape from the effect of hyperaldosteronemia.
J Membr Biol
133:
203-211,
1993[ISI][Medline].
350.
Wilson, PD,
and
Horster MF.
Differential response to hormones of defined distal nephron epithelia in culture.
Am J Physiol Cell Physiol
244:
C166-C174,
1983[Abstract].
351.
Xia, P,
Kramer RM,
and
King GL.
Identification of the mechanism for the inhibition of Na+,K+-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2.
J Clin Invest
96:
733-740,
1995[ISI][Medline].
352.
Xu, Z-C,
Dunham PB,
Dyer B,
and
Blostein R.
Decline in number of Na-K pumps on low-K+ sheep reticulocytes during maturation is modulated by Lp antigen.
Am J Physiol Cell Physiol
266:
C1173-C1181,
1994
353.
Xu, Z-C,
Dunham PB,
Munzer JS,
Silvius JR,
and
Blostein R.
Rat kidney Na-K pumps incorporated into low-K+ sheep red blood cell membranes are stimulated by anti Lp antibody.
Am J Physiol Cell Physiol
263:
C1007-C1014,
1992
354.
Yamaguchi, I,
Walk SF,
Jose PA,
and
Felder RA.
Dopamine D2L receptors stimulate Na+/K+-ATPase activity in murine LTK- cells.
Mol Pharmacol
49:
373-378,
1996[Abstract].
355.
Yasuda, H,
Maeda K,
Sonobe M,
Kawabata T,
Terada M,
Hisanaga T,
Taniguchi Y,
Kikkawa R,
and
Shigeta Y.
Metabolic effect of PGE1 analogue 01206.CD on nerve Na+-K+-ATPase activity of rats with streptozocin-induced diabetes is mediated via cAMP: possible role of cAMP in diabetic neuropathy.
Prostaglandins
47:
367-378,
1994[Medline].
356.
Yeagle, PL,
Young J,
and
Rice D.
Effects of cholesterol on (Na++K+)-ATPase ATP hydrolyzing activity in bovine kidney.
Biochemistry
27:
6449-6452,
1988[ISI][Medline].
357.
Yuan, CM,
Manunta P,
Hamlyn JM,
Chen S,
Bohen E,
Yeun J,
Haddy FJ,
and
Pamnani MB.
Long-term ouabain administration produces hypertension in rats.
Hypertension
22:
178-187,
1993[Abstract].
358.
Zeidel, ML,
Brady HR,
and
Kohan DE.
Interleukin-1 inhibition of Na+-K+-ATPase in inner medullary collecting duct cells: role of PGE2.
Am J Physiol Renal Fluid Electrolyte Physiol
261:
F1013-F1016,
1991
359.
Zeidel, ML,
Brady HR,
Kone BC,
Gullans SR,
and
Brenner BM.
Endothelin, a peptide inhibitor of Na+-K+-ATPase in intact renal tubular epithelial cells.
Am J Physiol Cell Physiol
257:
C1101-C1107,
1989
360.
Zhang, C,
and
Mayeux PR.
Angiotensin II signaling activities the NO-cGMP pathway in rat proximal tubules.
Life Sci
63:
PL75-PL80,
1998[ISI][Medline].
361.
Zhang, Z,
Devarajan P,
Dorfman AL,
and
Morrow JS.
Structure of the ankyrin-binding domain of -Na,K-ATPase.
J Biol Chem
273:
18681-18684,
1998
362.
Zhao, N,
Lo LC,
Berova N,
Nakanishi K,
Tymiak AA,
Ludens JH,
and
Haupert GT.
Na,K-ATPase inhibitors from bovine hypothalamus and human serum are different from ouabain: nanogram scale CD structural analysis.
Biochemistry
34:
9893-9896,
1995[ISI][Medline].